Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Lung Cancer

  Free Subscription


Articles published in Clin Lung Cancer

Retrieve available abstracts of 547 articles:
HTML format



Single Articles


    July 2021
  1. KOOPMAN B, Groen HJM, Schuuring E, Hiltermann TJN, et al
    Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the Literature.
    Clin Lung Cancer. 2021 Jul 3. pii: S1525-7304(21)00178.
    PubMed     Abstract available


    June 2021
  2. YANG Y, Deng L, Yang Y, Zhang T, et al
    Efficacy and Safety of Combined Brain Radiotherapy and Immunotherapy in Non-Small-Cell Lung Cancer With Brain Metastases: A Systematic Review and Meta-Analysis.
    Clin Lung Cancer. 2021 Jun 24. pii: S1525-7304(21)00160.
    PubMed     Abstract available


  3. JACOBS CD, Mehta K, Gao J, Wang X, et al
    Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2021 Jun 24. pii: S1525-7304(21)00159.
    PubMed     Abstract available


  4. BARTA JA, Shusted CS, Ruane B, Pimpinelli M, et al
    Racial Differences in Lung Cancer Screening Beliefs and Screening Adherence.
    Clin Lung Cancer. 2021 Jun 13. pii: S1525-7304(21)00143.
    PubMed     Abstract available


  5. SAITO G, Kono M, Koyanagi Y, Miyashita K, et al
    Significance of Brain Imaging for Staging in Patients With Clinical Stage T1-2 N0 Non-Small-Cell Lung Cancer on Positron Emission Tomography/Computed Tomography.
    Clin Lung Cancer. 2021 Jun 13. pii: S1525-7304(21)00145.
    PubMed     Abstract available


  6. TSUI DCC, Kavanagh BD, Honce JM, Rossi C, et al
    Central Nervous System Response to Selpercartinib in Patient With RET-rearranged Non-small Cell Lung Cancer After Developing Leptomeningeal Disease on Pralsetinib.
    Clin Lung Cancer. 2021 Jun 12. pii: S1525-7304(21)00148.
    PubMed    


  7. HENDRIKS LEL, Remon J, Besse B
    Dorian Gray Syndrome of Upfront Immunotherapy in Patients With Non-Small-Cell Lung Cancer and High PD-L1 Expression.
    Clin Lung Cancer. 2021 Jun 12. pii: S1525-7304(21)00149.
    PubMed    


  8. SOCINSKI MA, Ozguroglu M, Villegas A, Daniel D, et al
    Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non-Small-Cell Lung Cancer (PACIFIC).
    Clin Lung Cancer. 2021 Jun 12. pii: S1525-7304(21)00144.
    PubMed     Abstract available


    May 2021
  9. GADGEEL S, Hirsch FR, Kerr K, Barlesi F, et al
    Comparison of SP142 and 22C3 Immunohistochemistry PD-L1 Assays for Clinical Efficacy of Atezolizumab in Non-Small Cell Lung Cancer: Results From the Randomized OAK Trial.
    Clin Lung Cancer. 2021 May 30. pii: S1525-7304(21)00101.
    PubMed     Abstract available


  10. LI Y, Zhang Y, Jia X, Jiang P, et al
    Effect of Immune-Related Adverse Events and Pneumonitis on Prognosis in Advanced Non-Small Cell Lung Cancer: A Comprehensive Systematic Review and Meta-analysis.
    Clin Lung Cancer. 2021 May 28. pii: S1525-7304(21)00098.
    PubMed     Abstract available


  11. LEAL JL, Alexander M, Itchins M, Wright GM, et al
    EGFR Exon 20 Insertion Mutations: Clinicopathological Characteristics and Treatment Outcomes in Advanced Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2021 May 16. pii: S1525-7304(21)00093.
    PubMed     Abstract available


  12. RIESS JW, Reckamp KL, Frankel P, Longmate J, et al
    Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878).
    Clin Lung Cancer. 2021 May 15. pii: S1525-7304(21)00094.
    PubMed     Abstract available


    April 2021
  13. HAMADA A, Soh J, Hata A, Nakamatsu K, et al
    Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-small-cell Lung Cancer: SQUAT trial (WJOG 12119L).
    Clin Lung Cancer. 2021 Apr 27. pii: S1525-7304(21)00090.
    PubMed     Abstract available


  14. OYANAGI J, Koh Y, Sato K, Teraoka S, et al
    Bloodborne Cytokines for Predicting Clinical Benefits and Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated With Anti-Programmed Cell Death 1 Inhibitors.
    Clin Lung Cancer. 2021 Apr 27. pii: S1525-7304(21)00091.
    PubMed     Abstract available


  15. BYERS LA, Navarro A, Schaefer E, Johnson M, et al
    A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer.
    Clin Lung Cancer. 2021 Apr 24. pii: S1525-7304(21)00089.
    PubMed     Abstract available


  16. FISHER A, Kim S, Farhat D, Belzer K, et al
    Risk Factors Associated with a Second Primary Lung Cancer in Patients with an Initial Primary Lung Cancer.
    Clin Lung Cancer. 2021 Apr 23. pii: S1525-7304(21)00088.
    PubMed     Abstract available


  17. MERKHOFER CM, Eaton KD, Martins RG, Ramsey SD, et al
    Impact of Clinical Trial Participation on Survival of Patients with Metastatic Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2021 Apr 22. pii: S1525-7304(21)00087.
    PubMed     Abstract available


  18. RAEZ LE, Carracedo C, Drusbosky LM, Velez M, et al
    EGFR L718V (+)/T790M (-) as a Mechanism of Resistance in Patients with Metastatic Non-small-cell Lung Cancer with EGFR L858R Mutations.
    Clin Lung Cancer. 2021 Apr 9. pii: S1525-7304(21)00072.
    PubMed    


    March 2021
  19. MORAN A, Wang Y, Dyer BA, Yip SSF, et al
    Prognostic Value of Computed Tomography and/or (18)F-Fluorodeoxyglucose Positron Emission Tomography Radiomics Features in Locally Advanced Non-small Cell Lung Cancer.
    Clin Lung Cancer. 2021 Mar 27. pii: S1525-7304(21)00069.
    PubMed     Abstract available


  20. ARRIETA O, Varela-Santoyo E, Cardona AF, Sanchez-Reyes R, et al
    Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2021 Mar 27. pii: S1525-7304(21)00068.
    PubMed     Abstract available


  21. KAO C, Powers E, Wu Y, Datto MB, et al
    Predictive Value of Combining Biomarkers for Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.
    Clin Lung Cancer. 2021 Mar 27. pii: S1525-7304(21)00071.
    PubMed     Abstract available


  22. SHEN Q, Kalyani FS, Qu J, Chen Z, et al
    A Case of Small Cell Lung Carcinoma Harboring an EML4-ALK Fusion with Partial Response to Crizotinib.
    Clin Lung Cancer. 2021 Mar 26. pii: S1525-7304(21)00066.
    PubMed    


  23. WEISS J, Goldschmidt J, Andric Z, Dragnev KH, et al
    Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies.
    Clin Lung Cancer. 2021 Mar 26. pii: S1525-7304(21)00064.
    PubMed     Abstract available


  24. BRAINSON CF, Huang B, Chen Q, McLouth LE, et al
    Description of a Lung Cancer Hotspot: Disparities in Lung Cancer Histology, Incidence, and Survival in Kentucky and Appalachian Kentucky.
    Clin Lung Cancer. 2021 Mar 26. pii: S1525-7304(21)00061.
    PubMed     Abstract available


  25. KELLER A, Ghanta S, Rodriguez-Lopez JL, Patel A, et al
    Utility of Prophylactic Cranial Irradiation for Extensive-Stage Small-Cell Lung Cancer in the MRI Screening Era.
    Clin Lung Cancer. 2021 Mar 26. pii: S1525-7304(21)00063.
    PubMed     Abstract available


  26. CABEZON-GUTIERREZ L, Custodio-Cabello S, Palka-Kotlowska M, Alonso-Viteri S, et al
    Biomarkers of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Beyond PD-L1.
    Clin Lung Cancer. 2021 Mar 24. pii: S1525-7304(21)00060.
    PubMed     Abstract available


  27. DALL'OLIO FG, Gelsomino F, Conci N, Marcolin L, et al
    PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non-small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
    Clin Lung Cancer. 2021 Mar 16. pii: S1525-7304(21)00057.
    PubMed     Abstract available


    February 2021
  28. SATOH H, Miyazaki K, Kagohashi K
    Letter to the Editor Regarding "Cutaneous Toxicities in Lung Cancer Patients on Immune Checkpoint Inhibitor Therapy".
    Clin Lung Cancer. 2021 Feb 27. pii: S1525-7304(21)00051.
    PubMed    


  29. GREGORC V, Mazzarella L, Lazzari C, Graziano P, et al
    Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2021 Feb 25. pii: S1525-7304(20)30350.
    PubMed     Abstract available


  30. KIKUCHI Y, Nakatani Y, Yamaguchi T
    Where Is the Primary Site of the Extra-Axial Chordoma Masquerading As Lung Cancer?
    Clin Lung Cancer. 2021 Feb 24. pii: S1525-7304(21)00047.
    PubMed    


  31. BALL S, Dash A, Igid HP, Thein KZ, et al
    Extra-axial Chordoma Masquerading as Lung Cancer.
    Clin Lung Cancer. 2021 Feb 23. pii: S1525-7304(21)00048.
    PubMed    


  32. ARGIRIS A, Miao J, Cristea MC, Chen AM, et al
    A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811).
    Clin Lung Cancer. 2021 Feb 19. pii: S1525-7304(21)00032.
    PubMed     Abstract available


  33. GARON EB, Cho BC, Reinmuth N, Lee KH, et al
    Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non-Small-Cell Lung Cancer (MYSTIC).
    Clin Lung Cancer. 2021 Feb 19. pii: S1525-7304(21)00033.
    PubMed     Abstract available


  34. KOGURE Y, Hashimoto H, Oki M
    A Randomized Phase III Study of Pembrolizumab Versus Pembrolizumab-Carboplatin-Pemetrexed for Locally Advanced or Metastatic Nonsquamous Non-small-cell Lung Cancer with PD-L1 50% or more (LAPLACE-50): Study Protocol.
    Clin Lung Cancer. 2021 Feb 19. pii: S1525-7304(21)00031.
    PubMed     Abstract available


  35. PENG L, Deng HY, Yang Y
    Lobe-specific Lymph Node Dissection for Clinical Stage IA Non-small-cell Lung Cancer: What do we know?
    Clin Lung Cancer. 2021 Feb 16. pii: S1525-7304(21)00030.
    PubMed    


  36. BOYCE-FAPPIANO D, Nguyen QN, Chapman BV, Allen PK, et al
    Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2021 Feb 7. pii: S1525-7304(21)00025.
    PubMed     Abstract available


  37. LIN X, Jiao H, Pang Z, Chen H, et al
    Lung Cancer and Granuloma Identification Using a Deep Learning Model to Extract 3-Dimensional Radiomics Features in CT Imaging.
    Clin Lung Cancer. 2021 Feb 6. pii: S1525-7304(21)00027.
    PubMed     Abstract available


  38. FERRARA MG, Martini M, D'Argento E, Forcella C, et al
    PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors.
    Clin Lung Cancer. 2021 Feb 5. pii: S1525-7304(20)30351.
    PubMed     Abstract available


  39. GOULART BHL, Chennupati S, Fedorenko CR, Ramsey SD, et al
    Access to Tyrosine Kinase Inhibitors and Survival in Patients with Advanced EGFR(+) and ALK(+) Positive Non-small-cell Lung Cancer Treated in the Real-World.
    Clin Lung Cancer. 2021 Feb 4. pii: S1525-7304(21)00022.
    PubMed     Abstract available


  40. SHINTANI T, Kishi N, Matsuo Y, Ogura M, et al
    Incidence and Risk Factors of Symptomatic Radiation Pneumonitis in Non-Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Consolidation Durvalumab.
    Clin Lung Cancer. 2021 Feb 4. pii: S1525-7304(21)00020.
    PubMed     Abstract available


  41. LI GJ, Tan H, Chen H, Parmar A, et al
    Immunotherapy and Stereotactic Ablative Radiotherapy for Lung Cancer with Co-existing Interstitial Lung Disease: A Case Report.
    Clin Lung Cancer. 2021 Feb 4. pii: S1525-7304(21)00021.
    PubMed    


  42. KIRKLAND RS, Kole AJ, Batra H, Boggs DH, et al
    Predictors of In-Hospital Death in Patients with Lung Cancer Admitted for Acute Radiation Pneumonitis: A Healthcare Cost and Utilization Project (HCUP) Analysis.
    Clin Lung Cancer. 2021 Feb 3. pii: S1525-7304(21)00019.
    PubMed     Abstract available


    January 2021
  43. KERRIGAN K, Wang X, Haaland B, Adamson B, et al
    Real World Characterization of Advanced Non-Small Cell Lung Cancer in Never Smokers by Actionable Mutation Status.
    Clin Lung Cancer. 2021 Jan 26. pii: S1525-7304(21)00016.
    PubMed     Abstract available


  44. MATTES MD, Eubank TD, Almubarak M, Wen S, et al
    A Prospective Trial Evaluating the Safety and Systemic Response From the Concurrent Use of Radiation Therapy with Checkpoint Inhibitor Immunotherapy in Metastatic Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2021 Jan 25. pii: S1525-7304(21)00015.
    PubMed     Abstract available


  45. SHUKLA NA, Althouse S, Meyer Z, Hanna N, et al
    Association of Immune-Related Adverse Events and Efficacy Outcomes With Consolidation Pembrolizumab After Chemoradiation in Patients With Inoperable Stage III Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2021 Jan 23. pii: S1525-7304(21)00002.
    PubMed     Abstract available


  46. MERRITT RE, Abdel-Rasoul M, D'Souza DM, Kneuertz PJ, et al
    Racial Disparities in Overall Survival and Surgical Treatment for Early Stage Lung Cancer by Facility Type.
    Clin Lung Cancer. 2021 Jan 22. pii: S1525-7304(21)00010.
    PubMed     Abstract available


  47. KEISER MF, Patel AB, Altan M
    Cutaneous Toxicities in Lung Cancer Patients on Immune Checkpoint Inhibitor Therapy.
    Clin Lung Cancer. 2021 Jan 22. pii: S1525-7304(21)00009.
    PubMed     Abstract available


  48. LIU J, Hui C, Ladbury C, Waddington T, et al
    Improved Survival Outcomes in Medically Fit Patients With Early-Stage Non-Small-Cell Lung Cancer Undergoing Stereotactic Body Radiotherapy.
    Clin Lung Cancer. 2021 Jan 19. pii: S1525-7304(21)00006.
    PubMed     Abstract available


  49. OWONIKOKO TK, Redman MW, Byers LA, Hirsch FR, et al
    Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair-Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G.
    Clin Lung Cancer. 2021 Jan 10. pii: S1525-7304(21)00004.
    PubMed     Abstract available


  50. CHAN SWS, Smith E, Aggarwal R, Balaratnam K, et al
    Systemic Inflammatory Markers of Survival in Epidermal Growth Factor-Mutated Non-Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis.
    Clin Lung Cancer. 2021 Jan 10. pii: S1525-7304(21)00005.
    PubMed     Abstract available


  51. LU S, Casarini I, Kato T, Cobo M, et al
    Osimertinib Maintenance After Definitive Chemoradiation in Patients With Unresectable EGFR Mutation Positive Stage III Non-small-cell Lung Cancer: LAURA Trial in Progress.
    Clin Lung Cancer. 2021 Jan 6. pii: S1525-7304(20)30337.
    PubMed     Abstract available


  52. AL-AHMADI A, Ardeshir-Larijani F, Fu P, Cao S, et al
    Next Generation Sequencing of Advanced Non-Small Cell Lung Cancer: Utilization Based on Race and Impact on Survival.
    Clin Lung Cancer. 2021;22:16-22.
    PubMed     Abstract available


    December 2020
  53. KAMIGAICHI A, Tsutani Y, Mimae T, Miyata Y, et al
    Prediction of Unexpected N2 Disease Associated With Clinical T1-2N0-1M0 Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2020 Dec 27. pii: S1525-7304(20)30364.
    PubMed     Abstract available


  54. YAMAMOTO N, Harada H, Okamoto I, Masuda N, et al
    Phase 2 Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2020 Dec 26. pii: S1525-7304(20)30366.
    PubMed     Abstract available


  55. MALLER B, Simmons VN, Byrne MM, Tanvetyanon T, et al
    Characteristics and Outcomes of Lung Cancer Screening Among Individuals With or Without Cancer History.
    Clin Lung Cancer. 2020 Dec 19. pii: S1525-7304(20)30349.
    PubMed     Abstract available


  56. WANG X, Jiang S, You X, Aramini B, et al
    Extended Sleeve Lobectomy is an Alternative for Centrally Located Lung Cancer With Superior Short- and Long-term Outcomes.
    Clin Lung Cancer. 2020 Dec 17. pii: S1525-7304(20)30345.
    PubMed     Abstract available


  57. RAZ DJ, Ismail MH, Haupt EC, Sun V, et al
    Improving Utilization of Lung Cancer Screening Through Incorporating a Video-Based Educational Tool Into Smoking Cessation Counseling.
    Clin Lung Cancer. 2020 Dec 15. pii: S1525-7304(20)30346.
    PubMed     Abstract available


  58. GERBER DE, Hamann HA, Dorsey O, Ahn C, et al
    Clinician Variation in Ordering and Completion of Low-Dose Computed Tomography for Lung Cancer Screening in a Safety-Net Medical System.
    Clin Lung Cancer. 2020 Dec 11. pii: S1525-7304(20)30344.
    PubMed     Abstract available


  59. BUSTAMANTE ALVAREZ JG, Janse S, Owen DH, Kiourtsis S, et al
    Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele Frequency.
    Clin Lung Cancer. 2020 Dec 2. pii: S1525-7304(20)30340.
    PubMed     Abstract available


  60. HYSELL K, Yusuf R, Barakat L, Virata M, et al
    Decreased Overall Survival in HIV-associated Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2020 Dec 2. pii: S1525-7304(20)30339.
    PubMed     Abstract available


  61. METZENMACHER M, Goetz M, Herold T, Stuschke M, et al
    Acquired Resistance to BRAF/MEK Inhibitor Therapy in BRAF-V(600)-mutated Squamous Cell Lung Cancer: Concurrent Evolvement of PTEN and MEK1 Mutations.
    Clin Lung Cancer. 2020 Dec 2. pii: S1525-7304(20)30341.
    PubMed    


    November 2020
  62. LI T, Pan K, Ellinwood AK, Cress RD, et al
    Survival Trends of Metastatic Lung Cancer in California by Age at Diagnosis, Gender, Race/Ethnicity, and Histology, 1990-2014.
    Clin Lung Cancer. 2020 Nov 24. pii: S1525-7304(20)30338.
    PubMed     Abstract available


  63. YIN W, Cheng J, Tang Z, Toruner G, et al
    MET Amplification (MET/CEP7 Ratio >/= 1.8) Is an Independent Poor Prognostic Marker in Patients With Treatment-naive Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2020 Nov 17. pii: S1525-7304(20)30335.
    PubMed     Abstract available


  64. HANDA Y, Tsutani Y, Mimae T, Miyata Y, et al
    Surgical Procedure Selection for Stage I Lung Cancer: Complex Segmentectomy versus Wedge Resection.
    Clin Lung Cancer. 2020 Nov 17. pii: S1525-7304(20)30331.
    PubMed     Abstract available


  65. LI XM, Li WF, Lin JT, Yan HH, et al
    Predictive and Prognostic Potential of TP53 in Patients With Advanced Non-Small-Cell Lung Cancer Treated With EGFR-TKI: Analysis of a Phase III Randomized Clinical Trial (CTONG 0901).
    Clin Lung Cancer. 2020 Nov 17. pii: S1525-7304(20)30334.
    PubMed     Abstract available


  66. BALASUBRAMANIAN A, Onggo J, Gunjur A, John T, et al
    Immune Checkpoint Inhibition With Chemoradiotherapy in Stage III Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis of Safety Results.
    Clin Lung Cancer. 2020 Nov 12. pii: S1525-7304(20)30333.
    PubMed     Abstract available


  67. SUN L, Davis CW, Hwang WT, Jeffries S, et al
    Outcomes in Patients With Non-small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy.
    Clin Lung Cancer. 2020 Nov 11. pii: S1525-7304(20)30327.
    PubMed     Abstract available


  68. ENRIGHT TL, Witt JS, Burr AR, Yadav P, et al
    Combined Immunotherapy and Stereotactic Radiotherapy Improves Neurologic Outcomes in Patients with Non-small-cell Lung Cancer Brain Metastases.
    Clin Lung Cancer. 2020 Nov 10. pii: S1525-7304(20)30324.
    PubMed     Abstract available


  69. BORGHAEI H, Redman MW, Kelly K, Waqar SN, et al
    SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study).
    Clin Lung Cancer. 2020 Nov 10. pii: S1525-7304(20)30325.
    PubMed     Abstract available


  70. NIE Y, Wang X, Yang F, Zhou Z, et al
    Surgical Prognosis of Synchronous Multiple Primary Lung Cancer: Systematic Review and Meta-Analysis.
    Clin Lung Cancer. 2020 Nov 5. pii: S1525-7304(20)30332.
    PubMed     Abstract available


  71. OWEN DH, Benner B, Pilcher C, Good L, et al
    Deep and Durable Response to Nivolumab and Temozolomide in Small-Cell Lung Cancer Associated With an Early Decrease in Myeloid-Derived Suppressor Cells.
    Clin Lung Cancer. 2020 Nov 2. pii: S1525-7304(20)30328.
    PubMed    


    October 2020
  72. HARATAKE N, Seto T
    NTRK Fusion-positive Non-small-cell Lung Cancer: The Diagnosis and Targeted Therapy.
    Clin Lung Cancer. 2020 Oct 24. pii: S1525-7304(20)30315.
    PubMed     Abstract available


  73. MERRITT RE, Abdel-Rasoul M, Fitzgerald M, D'Souza DM, et al
    Nomograms for Predicting Overall and Recurrence-free Survival From Pathologic Stage IA and IB Lung Cancer After Lobectomy.
    Clin Lung Cancer. 2020 Oct 22. pii: S1525-7304(20)30311.
    PubMed     Abstract available


  74. GARRANA SH, Dagogo-Jack I, Cobb R, Kuo AH, et al
    Clinical and Imaging Features of Non-Small-Cell Lung Cancer in Young Patients.
    Clin Lung Cancer. 2020 Oct 21. pii: S1525-7304(20)30314.
    PubMed     Abstract available


  75. MA J, Pi G, Bi J, Li Y, et al
    Concurrent Apatinib and Brain Radiotherapy in Patients With Brain Metastases From Driver Mutation-negative Non-small-cell Lung Cancer: Study Protocol for an Open-label Randomized Controlled Trial.
    Clin Lung Cancer. 2020 Oct 21. pii: S1525-7304(20)30309.
    PubMed     Abstract available


  76. RIUDAVETS M, Caramella C, Pradere P, Naltet C, et al
    Complete, Unpredictable, Multi-site Response Including Brain and Liver Metastases in a Patient With RET-rearranged Non-small-cell Lung Cancer Treated With Single-agent Immunotherapy: A Case Report.
    Clin Lung Cancer. 2020 Oct 21. pii: S1525-7304(20)30313.
    PubMed    


  77. MELE MC, Rinninella E, Cintoni M, Pulcini G, et al
    Nutritional Support in Lung Cancer Patients: The State of the Art.
    Clin Lung Cancer. 2020 Oct 21. pii: S1525-7304(20)30310.
    PubMed     Abstract available


  78. ASAHINA H, Tanaka K, Morita S, Maemondo M, et al
    A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non-Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801).
    Clin Lung Cancer. 2020 Oct 16. pii: S1525-7304(20)30305.
    PubMed     Abstract available


  79. FRIIS RB, Hjollund NH, Pappot H, Taarnhoj GA, et al
    Patient-Reported Outcome Measures Used in Routine Care Predict for Survival at Disease Progression in Patients With Advanced Lung Cancer.
    Clin Lung Cancer. 2020 Oct 15. pii: S1525-7304(20)30294.
    PubMed     Abstract available


  80. SHAH AT, Bernardo RJ, Berry GJ, Kudelko K, et al
    Two Cases of Pulmonary Tumor Thrombotic Microangiopathy Associated with ROS1-Rearranged Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2020 Oct 15. pii: S1525-7304(20)30302.
    PubMed    


  81. YU H, Brustugun OT, Ekman S, Botling J, et al
    Programmed Cell Death Ligand 1 Expression in Resected Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2020 Oct 15. pii: S1525-7304(20)30299.
    PubMed     Abstract available


  82. ZHAO Y, Mao Y, He J, Gao S, et al
    Lobe-specific Lymph Node Dissection in Clinical Stage IA Solid-dominant Non-small-cell Lung Cancer: A Propensity Score Matching Study.
    Clin Lung Cancer. 2020 Oct 15. pii: S1525-7304(20)30291.
    PubMed     Abstract available


  83. TANAKA H, Hasegawa Y, Makiguchi T, Okumura F, et al
    A Phase I/II Study of Biweekly Carboplatin and Nab-paclitaxel With Concurrent Radiotherapy for Patients With Locally Advanced Unresectable Stage III Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2020 Oct 14. pii: S1525-7304(20)30296.
    PubMed     Abstract available


  84. ZHANG J, Liu L, Wang G, Li S, et al
    Skip N2 Metastasis Shows Similar Prognosis to N1 Disease in Lung Cancer: Mechanism Discussion.
    Clin Lung Cancer. 2020 Oct 14. pii: S1525-7304(20)30306.
    PubMed    


  85. HE Z, Li Z, Xu S, Wu W, et al
    Prognostic Significance of Lymph Node Count Removed at Sublobar Resection in Pathologic Stage IA Non-Small-cell Lung Cancer: A Population-Based Analysis.
    Clin Lung Cancer. 2020 Oct 14. pii: S1525-7304(20)30295.
    PubMed     Abstract available


  86. JANSEN AME, Sriram JD, Pluim D, Maas RJH, et al
    Therapeutic Exposure and Successful Response to Pembrolizumab in a Patient With Non-Small-Cell Lung Cancer Despite Significant Renal Loss Due to Paraneoplastic Nephrotic Syndrome.
    Clin Lung Cancer. 2020 Oct 14. pii: S1525-7304(20)30303.
    PubMed    


  87. WAQAR SN, Redman MW, Arnold SM, Hirsch FR, et al
    A Phase II Study of Telisotuzumab Vedotin in Patients With c-MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753).
    Clin Lung Cancer. 2020 Oct 14. pii: S1525-7304(20)30293.
    PubMed     Abstract available


  88. PARK M, Ho DY, Wakelee HA, Neal JW, et al
    Opportunistic Invasive Fungal Infections Mimicking Progression of Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2020 Oct 13. pii: S1525-7304(20)30292.
    PubMed     Abstract available


    September 2020
  89. ZHU YJ, Qu X, Zhan DD, Chen HH, et al
    Specific Gene Co-variation Acts Better Than Number of Concomitant Altered Genes in Predicting EGFR-TKI Efficacy in Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2020 Sep 19. pii: S1525-7304(20)30264.
    PubMed     Abstract available


  90. CITARELLA F, Russano M, Galletti A, Vincenzi B, et al
    Multiple and Concomitant Molecular Findings in a Heavily Treated Patient With EGFR-positive Lung Cancer.
    Clin Lung Cancer. 2020 Sep 18. pii: S1525-7304(20)30262.
    PubMed    


  91. CUSHMAN TR, Jones B, Akhavan D, Rusthoven CG, et al
    The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States.
    Clin Lung Cancer. 2020 Sep 18. pii: S1525-7304(20)30265.
    PubMed     Abstract available


  92. DENG Z, Qin Y, Liu Y, Zhang Y, et al
    Role of Antiangiogenic Agents Combined With EGFR Tyrosine Kinase Inhibitors in Treatment-naive Lung Cancer: A Meta-Analysis.
    Clin Lung Cancer. 2020 Sep 18. pii: S1525-7304(20)30271.
    PubMed     Abstract available


  93. VAN DE WIEL M, Derijcke S, Galdermans D, Daenen M, et al
    Coping Strategy Influences Quality of Life in Patients With Advanced Lung Cancer by Mediating Mood.
    Clin Lung Cancer. 2020 Sep 18. pii: S1525-7304(20)30274.
    PubMed     Abstract available


  94. SPIGEL DR, Jotte RM, Aix SP, Gressot L, et al
    Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial.
    Clin Lung Cancer. 2020 Sep 18. pii: S1525-7304(20)30270.
    PubMed     Abstract available


  95. EKEKE CN, Mitchell C, Schuchert M, Dhupar R, et al
    Early Distant Recurrence in Patients With Resected Stage I Lung Cancer: A Case Series of "Blast Metastasis".
    Clin Lung Cancer. 2020 Sep 18. pii: S1525-7304(20)30263.
    PubMed     Abstract available


  96. GOWER A, Kim J, Spector K, Menashe D, et al
    Three Primary Tumors Including EGFR-mutated Non-Small Cell Lung Cancer as First Presentation in Patient With Li-Fraumeni Syndrome.
    Clin Lung Cancer. 2020 Sep 18. pii: S1525-7304(20)30267.
    PubMed    


  97. BOWMAN L, Tiu R, Smyth EN, Willard MD, et al
    Clinical Characteristics, Treatments, and Concurrent Mutations in Non-Small Cell Lung Cancer Patients With NF1 Mutations.
    Clin Lung Cancer. 2020 Sep 18. pii: S1525-7304(20)30275.
    PubMed     Abstract available


  98. JAHANZEB M, Lin HM, Pan X, Yin Y, et al
    Immunotherapy Treatment Patterns and Outcomes Among ALK-Positive Patients With Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2020 Sep 18. pii: S1525-7304(20)30268.
    PubMed     Abstract available


  99. PASSARO A, Spitaleri G, de Marinis F
    Reply.
    Clin Lung Cancer. 2020;21:e415-e416.
    PubMed    


  100. CALIMAN E, Petreni P, Brugia M, Antonuzzo L, et al
    In Regard to "Activity of EGFR TKIs in Caucasian Patients With NSCLC Harbouring Potentially Sensitive Uncommon EGFR Mutations".
    Clin Lung Cancer. 2020;21:e363-e365.
    PubMed    


    August 2020
  101. BONOMI M, Maltese M, Brighenti M, Muri M, et al
    Tocilizumab for COVID-19 Pneumonia in a Patient With Non-Small-cell Lung Cancer Treated With Chemoimmunotherapy.
    Clin Lung Cancer. 2020 Aug 26. pii: S1525-7304(20)30254.
    PubMed    


  102. GOROSPE L, Ayala-Carbonero AM, Paredes-Rodriguez P, Munoz-Molina GM, et al
    Challenges in Management of Patients With Lung Cancer in Times of COVID-19: An Imaging Perspective.
    Clin Lung Cancer. 2020 Aug 25. pii: S1525-7304(20)30253.
    PubMed    


  103. SOOD S, Ganju R, Shen X, Napel MT, et al
    Ultra-central Thoracic Re-irradiation Using 10-fraction Stereotactic Body Radiotherapy for Recurrent Non-small-cell Lung Cancer Tumors: Preliminary Toxicity and Efficacy Outcomes.
    Clin Lung Cancer. 2020 Aug 11. pii: S1525-7304(20)30150.
    PubMed     Abstract available


  104. OH MS, Guzner A, Wainwright DA, Mohindra NA, et al
    The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
    Clin Lung Cancer. 2020 Aug 5. pii: S1525-7304(20)30238.
    PubMed     Abstract available


  105. CHIC N, Mezquita L, Aldea M, Chebib R, et al
    Successful Switch to Vemurafenib Plus Cobimetinib After Dabrafenib Plus Trametinib Toxicity in BRAF(V600E)-Mutant Metastatic Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2020 Aug 5. pii: S1525-7304(20)30235.
    PubMed    


  106. PASSIGLIA F, Bironzo P, Righi L, Listi A, et al
    A Prospective Phase II Single-arm Study of Niraparib Plus Dostarlimab in Patients With Advanced Non-small-cell Lung Cancer and/or Malignant Pleural Mesothelioma, Positive for PD-L1 Expression and Germline or Somatic Mutations in the DNA Repair Genes:
    Clin Lung Cancer. 2020 Aug 5. pii: S1525-7304(20)30236.
    PubMed     Abstract available


    July 2020
  107. CHEN XR, Hou X, Li DL, Sai K, et al
    Management of Non-Small-Cell Lung Cancer Patients Initially Diagnosed With 1 to 3 Synchronous Brain-Only Metastases: A Retrospective Study.
    Clin Lung Cancer. 2020 Jul 30. pii: S1525-7304(20)30233.
    PubMed     Abstract available


  108. DARWIN A, Rose T, Tandon A, Tanvetyanon T, et al
    Development of Bronchopleural Fistula After Durvalumab Consolidation for Stage III Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2020 Jul 30. pii: S1525-7304(20)30232.
    PubMed    


  109. MANKUZHY NP, Almahariq MF, Siddiqui ZA, Thompson AB, et al
    The Role of Postoperative Radiation Therapy for pN2 Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2020 Jul 30. pii: S1525-7304(20)30230.
    PubMed     Abstract available


  110. HALL PE, Ready N, Johnston A, Bomalaski JS, et al
    Phase II Study of Arginine Deprivation Therapy With Pegargiminase in Patients With Relapsed Sensitive or Refractory Small-cell Lung Cancer.
    Clin Lung Cancer. 2020 Jul 30. pii: S1525-7304(20)30234.
    PubMed     Abstract available


  111. STENEHJEM DD, Lubinga SJ, Gupte-Singh K, Zhang Y, et al
    Real-World Effectiveness of Nivolumab Monotherapy After Prior Systemic Therapy in Advanced Non-Small-Cell Lung Cancer in the United States.
    Clin Lung Cancer. 2020 Jul 29. pii: S1525-7304(20)30231.
    PubMed     Abstract available


  112. ZHENG J, Shen L, Jiang N, Zhu Y, et al
    First-in-Human Phase 1 Study of ES-072, an Oral Mutant-Selective EGFR T790M Inhibitor, in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2020 Jul 9. pii: S1525-7304(20)30223.
    PubMed     Abstract available


  113. CHANG Q, Xu J, Qiang H, Teng J, et al
    EGFR Tyrosine Kinase Inhibitor (TKI) Combined With Concurrent or Sequential Chemotherapy for Patients With Advanced Lung Cancer and Gradual Progression After First-Line EGFR-TKI Therapy: A Randomized Controlled Study.
    Clin Lung Cancer. 2020 Jul 6. pii: S1525-7304(20)30187.
    PubMed     Abstract available


  114. BLAKELY AM, Hu H, Wong FL, Raz DJ, et al
    Deterioration in Health-Related Quality of Life Diminishes Benefit of Lung Cancer Resection in Older Adults.
    Clin Lung Cancer. 2020 Jul 3. pii: S1525-7304(20)30216.
    PubMed     Abstract available


  115. SHEIKHBAHAEI S, Verde F, Hales RK, Rowe SP, et al
    Imaging in Therapy Response Assessment and Surveillance of Lung Cancer: Evidenced-based Review With Focus on the Utility of (18)F-FDG PET/CT.
    Clin Lung Cancer. 2020 Jul 3. pii: S1525-7304(20)30214.
    PubMed     Abstract available


  116. MERRITT RE, Kneuertz PJ
    Considerations for the Surgical Management of Early Stage Lung Cancer During the COVID-19 Pandemic.
    Clin Lung Cancer. 2020 Jul 3. pii: S1525-7304(20)30218.
    PubMed     Abstract available


  117. BOURHIS A, Remoue A, Uguen A
    KRAS and BRAF Double Mutations and Functional Classes of BRAF Mutations in Non-small-cell Lung Cancers.
    Clin Lung Cancer. 2020;21:e240-e242.
    PubMed    


    June 2020
  118. WONG W, Wu N, Gupta R, Mansfield AS, et al
    Utilization Trends and Factors Associated With ROS1 Testing Among Patients With Advanced Non-small-cell Lung Cancer in US Community Practices.
    Clin Lung Cancer. 2020 Jun 29. pii: S1525-7304(20)30213.
    PubMed     Abstract available


  119. MIERAS A, Pasman HRW, Klop HT, Onwuteaka-Philipsen BD, et al
    What Goals Do Patients and Oncologists Have When Starting Medical Treatment for Metastatic Lung Cancer?
    Clin Lung Cancer. 2020 Jun 21. pii: S1525-7304(20)30208.
    PubMed     Abstract available


  120. RECKAMP KL, Patil T, Kirtane K, Rich TA, et al
    Duration of Targeted Therapy in Patients With Advanced Non-small-cell Lung Cancer Identified by Circulating Tumor DNA Analysis.
    Clin Lung Cancer. 2020 Jun 20. pii: S1525-7304(20)30209.
    PubMed     Abstract available


  121. AUGUSTYN A, Adams DL, He J, Qiao Y, et al
    Giant Circulating Cancer-Associated Macrophage-Like Cells Are Associated With Disease Recurrence and Survival in Non-Small-Cell Lung Cancer Treated With Chemoradiation and Atezolizumab.
    Clin Lung Cancer. 2020 Jun 20. pii: S1525-7304(20)30210.
    PubMed     Abstract available


  122. ZHAO Y, Zhai L, Deng L, Halmos B, et al
    Efficacy of Osimertinib in Afatinib-resistant Lung Cancer Harboring Uncommon EGFR Mutations: Case Report and Literature Review.
    Clin Lung Cancer. 2020 Jun 19. pii: S1525-7304(20)30211.
    PubMed    


  123. MULLER DA, Dutta SW, Aliotta E, Sanders JC, et al
    Clinical Outcomes and Predictors of Lung Toxicity After Multiple Courses of Lung Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2020 Jun 12. pii: S1525-7304(20)30188.
    PubMed     Abstract available


  124. PATEL JD, Lee JW, Carbone DP, Wagner H, et al
    Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508).
    Clin Lung Cancer. 2020 Jun 12. pii: S1525-7304(20)30189.
    PubMed     Abstract available


  125. COSTA GJ, Silva GTD, Ferreira CG, Mello MJG, et al
    Brazilian Women With Lung Cancer Have a Higher Overall Survival Than Their Male Equivalents: A Cohort Study.
    Clin Lung Cancer. 2020 Jun 6. pii: S1525-7304(20)30162.
    PubMed     Abstract available


  126. SEHGAL K, Bulumulle A, Brody H, Gill RR, et al
    Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2020 Jun 5. pii: S1525-7304(20)30168.
    PubMed     Abstract available


  127. TSIMBERIDOU AM, Elkin S, Dumanois R, Pritchard D, et al
    Clinical and Economic Value of Genetic Sequencing for Personalized Therapy in Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2020 Jun 5. pii: S1525-7304(20)30169.
    PubMed     Abstract available


  128. URBANSKA EM, Santoni-Rugiu E, Melchior LC, Carlsen JF, et al
    Intracranial Response of ALK(+) Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery.
    Clin Lung Cancer. 2020 Jun 4. pii: S1525-7304(20)30135.
    PubMed    


  129. GUERINI AE, Borghetti P, Filippi AR, Bonu ML, et al
    Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab.
    Clin Lung Cancer. 2020 Jun 2. pii: S1525-7304(20)30167.
    PubMed    


  130. SITTENFELD SMC, Juloori A, Reddy CA, Stephans KL, et al
    Salvage Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Primary Surgical Resection of Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2020 Jun 2. pii: S1525-7304(20)30165.
    PubMed     Abstract available


  131. UPRETY D, Borgert AJ, Fitzsimmons AJ, Parsons BM, et al
    External Validation of AJCC Eighth Edition of Non-small-cell Lung Cancer Staging Among African Americans.
    Clin Lung Cancer. 2020 Jun 2. pii: S1525-7304(20)30170.
    PubMed     Abstract available


  132. ELBANNA M, Shiue K, Edwards D, Cerra-Franco A, et al
    Impact of Lung Parenchymal-Only Failure on Overall Survival in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy.
    Clin Lung Cancer. 2020 Jun 2. pii: S1525-7304(20)30164.
    PubMed     Abstract available


    May 2020
  133. BYLICKI O, Riviere F, Tournier C, Canoui-Poitrine F, et al
    Factors Associated With Aggressiveness of End-of-Life Care for Lung Cancer Patients and Associated Costs of Care.
    Clin Lung Cancer. 2020 May 23. pii: S1525-7304(20)30157.
    PubMed     Abstract available


  134. HIRSCH EA, New ML, Brown SL, Baron AE, et al
    Impact of a Hybrid Lung Cancer Screening Model on Patient Outcomes and Provider Behavior.
    Clin Lung Cancer. 2020 May 23. pii: S1525-7304(20)30158.
    PubMed     Abstract available


  135. FRIEDES C, Mai N, Hazell S, Fu W, et al
    Consolidative Radiotherapy in Oligometastatic Lung Cancer: Patient Selection With a Prediction Nomogram.
    Clin Lung Cancer. 2020 May 23. pii: S1525-7304(20)30153.
    PubMed     Abstract available


  136. GIJTENBEEK RGP, Damhuis RAM, Groen HJM, van der Wekken AJ, et al
    Nationwide Real-world Cohort Study of First-line Tyrosine Kinase Inhibitor Treatment in Epidermal Growth Factor Receptor-mutated Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2020 May 22. pii: S1525-7304(20)30159.
    PubMed     Abstract available


  137. MIURA S, Yamanaka T, Kato T, Ikeda S, et al
    Treatment Rationale and Design of a Phase III Study of Afatinib or Chemotherapy in Patients with Non-small-cell Lung Cancer Harboring Sensitizing Uncommon Epidermal Growth Factor Receptor Mutations (ACHILLES/TORG1834).
    Clin Lung Cancer. 2020 May 21. pii: S1525-7304(20)30151.
    PubMed     Abstract available


  138. ENDOH H, Yamamoto R, Ichikawa A, Shiozawa S, et al
    Clinicopathologic Significance of False-Positive Lymph Node Status on FDG-PET in Lung Cancer.
    Clin Lung Cancer. 2020 May 14. pii: S1525-7304(20)30142.
    PubMed     Abstract available


  139. LUCIANI A, Marra A, Toschi L, Cortinovis D, et al
    Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged >/= 75 Years With Non-small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study.
    Clin Lung Cancer. 2020 May 13. pii: S1525-7304(20)30144.
    PubMed     Abstract available


  140. CHIANG AC, Sequist LVD, Gilbert J, Conkling P, et al
    Clinical Activity and Safety of Atezolizumab in a Phase 1 Study of Patients With Relapsed/Refractory Small-Cell Lung Cancer.
    Clin Lung Cancer. 2020 May 12. pii: S1525-7304(20)30148.
    PubMed     Abstract available


  141. BALL S, Dash A, Igid HP, Thein KZ, et al
    Primary Extra-axial Chordoma Masquerading as Lung Cancer: Case Report and Review of the Literature.
    Clin Lung Cancer. 2020 May 11. pii: S1525-7304(20)30141.
    PubMed    


  142. GOBBINI E, Toffart AC, Perol M, Assie JB, et al
    Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer Patients.
    Clin Lung Cancer. 2020 May 8. pii: S1525-7304(20)30136.
    PubMed     Abstract available


  143. KAMIGAICHI A, Tsutani Y, Kagimoto A, Fujiwara M, et al
    Comparing Segmentectomy and Lobectomy for Clinical Stage IA Solid-dominant Lung Cancer Measuring 2.1 to 3 cm.
    Clin Lung Cancer. 2020 May 7. pii: S1525-7304(20)30138.
    PubMed     Abstract available


  144. IJSSELDIJK MA, Shoni M, Siegert C, Wiering B, et al
    Oncologic Outcomes of Surgery Versus SBRT for Non-Small-Cell Lung Carcinoma: A Systematic Review and Meta-analysis.
    Clin Lung Cancer. 2020 May 7. pii: S1525-7304(20)30140.
    PubMed     Abstract available


    April 2020
  145. FRIEDLAENDER A, Liu SV, Passaro A, Metro G, et al
    The Role of Performance Status in Small-Cell Lung Cancer in the Era of Immune Checkpoint Inhibitors.
    Clin Lung Cancer. 2020 Apr 30. pii: S1525-7304(20)30105.
    PubMed     Abstract available


  146. MORAN T, Taus A, Arriola E, Aguado C, et al
    Clinical Activity of Afatinib in Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Spanish Retrospective Multicenter Study.
    Clin Lung Cancer. 2020 Apr 25. pii: S1525-7304(20)30134.
    PubMed     Abstract available


  147. STINCHCOMBE TE, Miksad RA, Gossai A, Griffith SD, et al
    Real-World Outcomes for Advanced Non-Small Cell Lung Cancer Patients Treated With a PD-L1 Inhibitor Beyond Progression.
    Clin Lung Cancer. 2020 Apr 18. pii: S1525-7304(20)30107.
    PubMed     Abstract available


  148. DE GIGLIO A, Lamberti G, Facchinetti F, Genova C, et al
    Treatment Patterns and Clinical Outcomes Among Patients With ROS1-rearranged Non-small-cell Lung Cancer Progressing on Crizotinib.
    Clin Lung Cancer. 2020 Apr 15. pii: S1525-7304(20)30087.
    PubMed     Abstract available


  149. SHEN E, Xiu J, Bentley R, Lopez GY, et al
    Frequent Mutations of POT1 Distinguish Pulmonary Sarcomatoid Carcinoma From Other Lung Cancer Histologies.
    Clin Lung Cancer. 2020 Apr 15. pii: S1525-7304(20)30101.
    PubMed     Abstract available


  150. GELATTI ACZ, Cordeiro de Lima VC, Freitas H, Werutsky G, et al
    Real-World Prevalence of PD-L1 Expression Among Tumor Samples From Patients With Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2020 Apr 13. pii: S1525-7304(20)30106.
    PubMed     Abstract available


  151. ABDEL-RAHMAN O
    Incidence and Mortality of Lung Cancer Among Never Smokers in Relationship to Secondhand Smoking: Findings From the PLCO Trial.
    Clin Lung Cancer. 2020 Apr 13. pii: S1525-7304(20)30108.
    PubMed     Abstract available


  152. CATHCART-RAKE EJ, Sangaralingham LR, Henk HJ, Shah ND, et al
    A Population-based Study of Immunotherapy-related Toxicities in Lung Cancer.
    Clin Lung Cancer. 2020 Apr 13. pii: S1525-7304(20)30102.
    PubMed     Abstract available


  153. KIM J, Hyun HJ, Choi EA, Yoo JW, et al
    Diabetes, Metformin, and Lung Cancer: Retrospective Study of the Korean NHIS-HEALS Database.
    Clin Lung Cancer. 2020 Apr 13. pii: S1525-7304(20)30100.
    PubMed     Abstract available


  154. MUKTHINUTHALAPATI VVPK, Putta A, Farooq MZ, Singh SRK, et al
    Knowledge, Attitudes, and Practices Pertaining to Lung Cancer Screening Among Primary Care Physicians in a Public Urban Health Network.
    Clin Lung Cancer. 2020 Apr 11. pii: S1525-7304(20)30083.
    PubMed     Abstract available


  155. SHIRAISHI Y, Kishimoto J, Tanaka K, Sugawara S, et al
    Treatment Rationale and Design for APPLE (WJOG11218L): A Multicenter, Open-Label, Randomized Phase 3 Study of Atezolizumab and Platinum/Pemetrexed With or Without Bevacizumab for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2020 Apr 10. pii: S1525-7304(20)30089.
    PubMed     Abstract available


  156. MAYNE NR, Mallipeddi MK, Darling AJ, Jeffrey Yang CF, et al
    Impact of Surveillance After Lobectomy for Lung Cancer on Disease Detection and Survival.
    Clin Lung Cancer. 2020 Apr 10. pii: S1525-7304(20)30099.
    PubMed     Abstract available


    March 2020
  157. CHIAPPETTA M, Leuzzi G, Sperduti I, Bria E, et al
    Mediastinal Up-Staging During Surgery in Non-Small-Cell Lung Cancer: Which Mediastinal Lymph Node Metastasis Patterns Better Predict The Outcome? A Multicenter Analysis.
    Clin Lung Cancer. 2020 Mar 20. pii: S1525-7304(20)30082.
    PubMed     Abstract available


  158. MARTINEZ-MEEHAN D, Lutfi W, Dhupar R, Christie N, et al
    Factors Associated With Survival in Complete Pathologic Response Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2020 Mar 16. pii: S1525-7304(20)30081.
    PubMed     Abstract available


  159. SHUKLA NA, Yan MN, Hanna N
    The Story of Angiogenesis Inhibitors in Non-small-cell Lung Cancer: The Past, Present, and Future.
    Clin Lung Cancer. 2020 Mar 12. pii: S1525-7304(20)30075.
    PubMed     Abstract available


  160. MINARI R, Mazzaschi G, Bordi P, Gnetti L, et al
    Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Rea
    Clin Lung Cancer. 2020 Mar 9. pii: S1525-7304(20)30072.
    PubMed     Abstract available


  161. NAIDOO J, Nishino M, Patel SP, Shankar B, et al
    Immune-Related Pneumonitis After Chemoradiotherapy and Subsequent Immune Checkpoint Blockade in Unresectable Stage III Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2020 Mar 9. pii: S1525-7304(20)30076.
    PubMed     Abstract available


  162. FARRELL MJ, Yahya JB, Degnin C, Chen Y, et al
    Elective Nodal Irradiation for Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Practice Patterns.
    Clin Lung Cancer. 2020 Mar 7. pii: S1525-7304(20)30071.
    PubMed     Abstract available


  163. PRELAJ A, Rebuzzi SE, Pizzutilo P, Bilancia M, et al
    EPSILoN: A Prognostic Score Using Clinical and Blood Biomarkers in Advanced Non-Small-cell Lung Cancer Treated With Immunotherapy.
    Clin Lung Cancer. 2020 Mar 7. pii: S1525-7304(19)30334.
    PubMed     Abstract available


  164. PRELAJ A, Lo Russo G, Proto C, Signorelli D, et al
    DiM: Prognostic Score for Second- or Further-line Immunotherapy in Advanced Non-Small-Cell Lung Cancer: An External Validation.
    Clin Lung Cancer. 2020 Mar 7. pii: S1525-7304(20)30005.
    PubMed     Abstract available


  165. RAJU S, Khawaja A, Han X, Wang X, et al
    Lung Cancer Screening: Characteristics of Nonparticipants and Potential Screening Barriers.
    Clin Lung Cancer. 2020 Mar 3. pii: S1525-7304(19)30333.
    PubMed     Abstract available


  166. GELSOMINO F, Di Federico A, Filippini DM, Dall'Olio FG, et al
    Overcoming Primary Resistance to PD-1 Inhibitor With Anti-PD-L1 Agent in Squamous-Cell NSCLC: Case Report.
    Clin Lung Cancer. 2020;21:e45-e48.
    PubMed    


  167. BARBOSA MVR, Cordeiro de Lima VC, Formiga MN, Andrade de Paula CA, et al
    High Prevalence of EGFR Mutations in Lung Adenocarcinomas From Brazilian Patients Harboring the TP53 p.R337H Variant.
    Clin Lung Cancer. 2020;21:e37-e44.
    PubMed    


  168. MATSUBARA T, Uchi H, Haratake N, Takamori S, et al
    Acute Generalized Exanthematous Pustulosis Caused by the Combination of Pembrolizumab Plus Chemotherapy in a Patient With Squamous-Cell Carcinoma.
    Clin Lung Cancer. 2020;21:e54-e56.
    PubMed    


  169. MAZZASCHI G, Bordi P, Fioretzaki R, Gnetti L, et al
    Nivolumab-Induced Guillain-Barre Syndrome Coupled With Remarkable Disease Response in a Case of Heavily Pretreated Lung Adenocarcinoma.
    Clin Lung Cancer. 2020;21:e65-e73.
    PubMed    


  170. TANNER NT, Brasher PB, Jett J, Silvestri GA, et al
    Effect of a Rule-in Biomarker Test on Pulmonary Nodule Management: A Survey of Pulmonologists and Thoracic Surgeons.
    Clin Lung Cancer. 2020;21:e89-e98.
    PubMed     Abstract available


  171. ZHANG Y, Yu M, Yuan M, Chen R, et al
    Identification of a Novel RBPMS-ROS1 Fusion in an Adolescent Patient With Microsatellite-instable Advanced Lung Adenocarcinoma Sensitive to Crizotinib: A Case Report.
    Clin Lung Cancer. 2020;21:e78-e83.
    PubMed    


  172. KINSLOW CJ, May MS, Saqi A, Shu CA, et al
    Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.
    Clin Lung Cancer. 2020;21:e99-e113.
    PubMed     Abstract available


  173. ERSEK JL, Symanowski JT, Han Y, Howard A, et al
    Pulmonary Carcinosarcoma: A Surveillance, Epidemiology, and End Results (SEER) Analysis.
    Clin Lung Cancer. 2020;21:160-170.
    PubMed     Abstract available


    February 2020
  174. GERBER DE, Hamann HA, Chavez C, Dorsey O, et al
    Tracking the Nonenrolled: Lung Cancer Screening Patterns Among Individuals not Accrued to a Clinical Trial.
    Clin Lung Cancer. 2020 Feb 26. pii: S1525-7304(20)30035.
    PubMed     Abstract available


  175. MIYAWAKI T, Kenmotsu H, Mori K, Miyawaki E, et al
    Association Between Clinical Tumor Burden and Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2020 Feb 26. pii: S1525-7304(20)30037.
    PubMed     Abstract available


  176. FORDE PM, Bonomi P, Shaw A, Blumenthal GM, et al
    Expanding Access to Lung Cancer Clinical Trials by Reducing the Use of Restrictive Exclusion Criteria: Perspectives of a Multistakeholder Working Group.
    Clin Lung Cancer. 2020 Feb 26. pii: S1525-7304(20)30033.
    PubMed     Abstract available


  177. TAMBO Y, Sone T, Shibata K, Nishi K, et al
    Real-World Efficacy of First-Line Pembrolizumab in Patients With Advanced or Recurrent Non-Small-Cell Lung Cancer and High PD-L1 Tumor Expression.
    Clin Lung Cancer. 2020 Feb 26. pii: S1525-7304(20)30042.
    PubMed     Abstract available


  178. RITTBERG R, Green S, Aquin T, Bucher O, et al
    Effect of Hospitalization During First Chemotherapy and Performance Status on Small-cell Lung Cancer Outcomes.
    Clin Lung Cancer. 2020 Feb 26. pii: S1525-7304(20)30038.
    PubMed     Abstract available


  179. MARTIN C, Lupinacci L, Perazzo F, Bas C, et al
    Efficacy and Safety of Nivolumab in Previously Treated Patients With Non-Small-cell Lung Cancer: Real World Experience in Argentina.
    Clin Lung Cancer. 2020 Feb 26. pii: S1525-7304(20)30039.
    PubMed     Abstract available


  180. FINK-NEUBOECK N, Lindenmann J, Porubsky C, Fediuk M, et al
    Hazards of Recurrence, Second Primary, or Other Tumor at Ten Years After Surgery for Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2020 Feb 26. pii: S1525-7304(20)30036.
    PubMed     Abstract available


  181. BAEK J, Owen DH, Merritt RE, Shilo K, et al
    Minimally Invasive Lobectomy for Residual Primary Tumors of Advanced Non-Small-Cell Lung Cancer After Treatment With Immune Checkpoint Inhibitors: Case Series and Clinical Considerations.
    Clin Lung Cancer. 2020 Feb 25. pii: S1525-7304(20)30041.
    PubMed    


  182. ZHAO Y, Dong Y, Zhao R, Zhang B, et al
    Expression Profiling of Driver Genes in Female Never-smokers With Non-adenocarcinoma Non-small-cell Lung Cancer in China.
    Clin Lung Cancer. 2020 Feb 10. pii: S1525-7304(20)30020.
    PubMed     Abstract available


  183. O'NEILL RS, Mohd Zaki NI, Grant C, Napaki S, et al
    A Case of Non-Small-cell Lung Cancer in a Patient With Neurofibromatosis Type 1.
    Clin Lung Cancer. 2020 Feb 8. pii: S1525-7304(20)30019.
    PubMed    


  184. HOSOYA K, Fujimoto D, Morimoto T, Kumagai T, et al
    Association Between Early Immune-related Adverse Events and Clinical Outcomes in Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
    Clin Lung Cancer. 2020 Feb 4. pii: S1525-7304(20)30003.
    PubMed     Abstract available


    January 2020
  185. HANDA Y, Tsutani Y, Shiroma N, Kai Y, et al
    Prognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer.
    Clin Lung Cancer. 2020 Jan 27. pii: S1525-7304(20)30013.
    PubMed     Abstract available


  186. RAJARAM R, Correa AM, Xu T, Nguyen QN, et al
    Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients.
    Clin Lung Cancer. 2020 Jan 27. pii: S1525-7304(20)30009.
    PubMed     Abstract available


  187. TANAKA I, Morise M, Miyazawa A, Kodama Y, et al
    Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer Patients With EGFR Mutation.
    Clin Lung Cancer. 2020 Jan 27. pii: S1525-7304(20)30011.
    PubMed     Abstract available


  188. PIZARRO G, Pinto MP, Munoz-Medel M, Cordova-Delgado M, et al
    Complete Response to Immunotherapy Plus Chemotherapy After an Unusual Clinical Response to Afatinib and Stereotactic Radiosurgery in a Patient With Metastatic EGFR-Mutant Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2020 Jan 27. pii: S1525-7304(20)30012.
    PubMed    


  189. ARNOLD SM, Chansky K, Baggstrom MQ, Thompson MA, et al
    Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based Chemotherapy.
    Clin Lung Cancer. 2020 Jan 27. pii: S1525-7304(20)30006.
    PubMed     Abstract available


  190. MARMARELIS ME, Langer CJ
    Treatment of Patients With Non-Small-Cell Lung Cancer Harboring Rare Oncogenic Mutations.
    Clin Lung Cancer. 2020 Jan 27. pii: S1525-7304(20)30010.
    PubMed     Abstract available


  191. AHMED T, Lycan T, Dothard A, Ehrlichman P, et al
    Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2020 Jan 23. pii: S1525-7304(20)30001.
    PubMed     Abstract available


  192. RAPHAEL J, Batra A, Boldt G, Shah PS, et al
    Predictors of Survival Benefit From Immune Checkpoint Inhibitors in Patients With Advanced Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis.
    Clin Lung Cancer. 2020 Jan 3. pii: S1525-7304(19)30321.
    PubMed     Abstract available


  193. MATTAR MS, Chang J, Benayed R, Halpenny D, et al
    Complete Pathological Response to Crizotinib in a Patient with ALK-rearranged Lung Adenocarcinoma.
    Clin Lung Cancer. 2020;21:e25-e29.
    PubMed    


  194. TSUTSUMI H, Yoneshima Y, Ota K, Otsubo K, et al
    Multiclonality and Radiosensitivity of Granulocyte-colony Stimulating Factor-Producing Lung Adenocarcinoma Positive for an Activating EGFR Mutation.
    Clin Lung Cancer. 2020;21:e21-e24.
    PubMed    


  195. FRANCESCHINI D, De Rose F, Cozzi S, Renna I, et al
    Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience.
    Clin Lung Cancer. 2020;21:86-93.
    PubMed     Abstract available


  196. DOI H, Kuribayashi K, Kitajima K, Yamakado K, et al
    Development of a Novel Prognostic Risk Classification System for Malignant Pleural Mesothelioma.
    Clin Lung Cancer. 2020;21:66-74.
    PubMed     Abstract available


  197. GUO HY, Lin JT, Huang HH, Gao Y, et al
    Development and Validation of a (18)F-FDG PET/CT-Based Clinical Prediction Model for Estimating Malignancy in Solid Pulmonary Nodules Based on a Population With High Prevalence of Malignancy.
    Clin Lung Cancer. 2020;21:47-55.
    PubMed     Abstract available


  198. CASTELLO A, Toschi L, Rossi S, Finocchiaro G, et al
    Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy.
    Clin Lung Cancer. 2020;21:28-36.
    PubMed     Abstract available


    December 2019
  199. TSAO MN, Ven LI', Cheung P, Poon I, et al
    Stereotactic Body Radiation Therapy for Extracranial Oligometastatic Non-small-cell Lung Cancer: A Systematic Review.
    Clin Lung Cancer. 2019 Dec 30. pii: S1525-7304(19)30324.
    PubMed     Abstract available


  200. VOGEL J, Simone CB 2nd
    Patient-reported Outcomes With Stereotactic Body Radiotherapy and Surgery for Lung Cancer.
    Clin Lung Cancer. 2019 Dec 28. pii: S1525-7304(19)30372.
    PubMed    


  201. SENAN S, Okamoto I, Lee GW, Chen Y, et al
    Design and Rationale for a Phase III, Randomized, Placebo-controlled Trial of Durvalumab With or Without Tremelimumab After Concurrent Chemoradiotherapy for Patients With Limited-stage Small-cell Lung Cancer: The ADRIATIC Study.
    Clin Lung Cancer. 2019 Dec 28. pii: S1525-7304(19)30374.
    PubMed     Abstract available


  202. ALBERTS L, Wolff HB, Kastelijn EA, Schramel FMNH, et al
    Patient-reported Outcomes After the Treatment of Early Stage Non-small-cell Lung Cancer With Stereotactic Body Radiotherapy Compared With Surgery.
    Clin Lung Cancer. 2019 Dec 28. pii: S1525-7304(19)30373.
    PubMed    


  203. KARACZ CM, Yan J, Zhu H, Gerber DE, et al
    Timing, Sites, and Correlates of Lung Cancer Recurrence.
    Clin Lung Cancer. 2019 Dec 20. pii: S1525-7304(19)30344.
    PubMed     Abstract available


  204. SHAH R, Lester JF
    Tyrosine Kinase Inhibitors for the Treatment of EGFR Mutation-Positive Non-Small-Cell Lung Cancer: A Clash of the Generations.
    Clin Lung Cancer. 2019 Dec 20. pii: S1525-7304(19)30346.
    PubMed     Abstract available


  205. FUKIHARA J, Sakamoto K, Koyama J, Ito T, et al
    Reply to "Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non-Small-Cell Lung Cancer Who Received Programmed Death-1 Inhibitors".
    Clin Lung Cancer. 2019 Dec 2. pii: S1525-7304(19)30330.
    PubMed    


    November 2019
  206. GUNJUR A, Chong G, Lim A, Lau E, et al
    Occult Gastrointestinal Perforation in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer Receiving Combination Chemotherapy With Atezolizumab and Bevacizumab: Brief Report.
    Clin Lung Cancer. 2019 Nov 29. pii: S1525-7304(19)30331.
    PubMed    


  207. STEFFEN MCLOUTH LE, Lycan TW Jr, Levine BJ, Gabbard J, et al
    Patient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non-Small-Cell Lung Cancer in Clinical Practice.
    Clin Lung Cancer. 2019 Nov 29. pii: S1525-7304(19)30332.
    PubMed     Abstract available


  208. SKOUGAARD K, Ostrup O, Guldbrandsen K, Sorensen B, et al
    Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy: A Randomized Controlled Trial (SUPER).
    Clin Lung Cancer. 2019 Nov 21. pii: S1525-7304(19)30319.
    PubMed     Abstract available


  209. BYEON S, Lee B, Park WY, Choi YL, et al
    Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests.
    Clin Lung Cancer. 2019 Nov 21. pii: S1525-7304(19)30323.
    PubMed     Abstract available


  210. PATIL T, Mushtaq R, Marsh S, Azelby C, et al
    Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2019 Nov 21. pii: S1525-7304(19)30325.
    PubMed     Abstract available


  211. HOCHMAIR MJ, Setinek U, Krenbek D, Fazekas A, et al
    Rapid Clinical and Radiologic Responses With Larotrectinib Treatment in a Patient With TRK-Fusion-Positive Metastatic Lung Cancer.
    Clin Lung Cancer. 2019 Nov 20. pii: S1525-7304(19)30327.
    PubMed    


  212. SURESH K, Naidoo J
    Lower Survival in Patients Who Develop Pneumonitis Following Immunotherapy for Lung Cancer.
    Clin Lung Cancer. 2019 Nov 6. pii: S1525-7304(19)30283.
    PubMed    


  213. JELINEK MJ, Armstrong SA, Patel JD, Subramaniam DS, et al
    Identifying Resistance Mechanisms to Osimertinib via Blood Biopsy.
    Clin Lung Cancer. 2019;20:e597-e600.
    PubMed    


  214. GUISIER F, Piton N, Salaun M, Thiberville L, et al
    ROS1-rearranged NSCLC With Secondary Resistance Mutation: Case Report and Current Perspectives.
    Clin Lung Cancer. 2019;20:e593-e596.
    PubMed    


  215. MODING EJ, Liang R, Lartey FM, Maxim PG, et al
    Predictors of Respiratory Decline Following Stereotactic Ablative Radiotherapy to Multiple Lung Tumors.
    Clin Lung Cancer. 2019;20:461-468.
    PubMed     Abstract available


  216. PROTO C, Signorelli D, Mallone S, Prelaj A, et al
    The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma.
    Clin Lung Cancer. 2019;20:e652-e660.
    PubMed     Abstract available


  217. SCHULZ C, Gandara D, Berardo CG, Rosenthal R, et al
    Comparative Efficacy of Second- and Subsequent-line Treatments for Metastatic NSCLC: A Fractional Polynomials Network Meta-analysis of Cancer Immunotherapies.
    Clin Lung Cancer. 2019;20:451-460.
    PubMed     Abstract available


    October 2019
  218. LE T, Yang H, Rashdan S, Link MS, et al
    QTc Interval-Prolonging Medications Among Patients With Lung Cancer: Implications for Clinical Trial Eligibility and Clinical Care.
    Clin Lung Cancer. 2019 Oct 31. pii: S1525-7304(19)30212.
    PubMed     Abstract available


  219. LELEU O, Basille D, Auquier M, Clarot C, et al
    Lung Cancer Screening by Low-Dose CT Scan: Baseline Results of a French Prospective Study.
    Clin Lung Cancer. 2019 Oct 31. pii: S1525-7304(19)30288.
    PubMed     Abstract available


  220. BEGNAUD A, Yang P, Robichaux C, Rubin N, et al
    Evidence That Established Lung Cancer Mortality Disparities in American Indians Are Not Due to Lung Cancer Genetic Testing and Targeted Therapy Disparities.
    Clin Lung Cancer. 2019 Oct 30. pii: S1525-7304(19)30286.
    PubMed     Abstract available


  221. ZHANG N, Wu J, Yu J, Zhu H, et al
    Integrating Imaging, Histologic, and Genetic Features to Predict Tumor Mutation Burden of Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2019 Oct 25. pii: S1525-7304(19)30290.
    PubMed     Abstract available


  222. DENG HY, Peng L
    Surgery or Stereotactic Body Radiotherapy for Early-stage Lung Cancer: What Is the Current Evidence?
    Clin Lung Cancer. 2019 Oct 22. pii: S1525-7304(19)30285.
    PubMed    


  223. CHAN ST, Ruan D, Shaverdian N, Raghavan G, et al
    Effect of Radiation Doses to the Heart on Survival for Stereotactic Ablative Radiotherapy for Early-stage Non-Small-cell Lung Cancer: An Artificial Neural Network Approach.
    Clin Lung Cancer. 2019 Oct 21. pii: S1525-7304(19)30284.
    PubMed     Abstract available


  224. JACOBS CD, Gao J, Wang X, Clarke JM, et al
    Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness.
    Clin Lung Cancer. 2019 Oct 19. pii: S1525-7304(19)30270.
    PubMed     Abstract available


  225. DIGUMARTHY SR, Mendoza DP, Lin JJ, Chen T, et al
    Computed Tomography Imaging Features and Distribution of Metastases in ROS1-rearranged Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2019 Oct 16. pii: S1525-7304(19)30271.
    PubMed     Abstract available


  226. ROGASCH JMM, Furth C, Chibolela C, Hofheinz F, et al
    Validation of Independent Prognostic Value of Asphericity of (18)F-Fluorodeoxyglucose Uptake in Non-Small-Cell Lung Cancer Patients Undergoing Treatment With Curative Intent.
    Clin Lung Cancer. 2019 Oct 15. pii: S1525-7304(19)30266.
    PubMed     Abstract available


  227. KNEUERTZ PJ, D'Souza DM, Richardson M, Abdel-Rasoul M, et al
    Long-Term Oncologic Outcomes After Robotic Lobectomy for Early-stage Non-Small-cell Lung Cancer Versus Video-assisted Thoracoscopic and Open Thoracotomy Approach.
    Clin Lung Cancer. 2019 Oct 13. pii: S1525-7304(19)30269.
    PubMed     Abstract available


  228. KOBAYASHI K, Nakachi I, Mitsuishi A, Arai D, et al
    Successful Retreatment Using Pembrolizumab for Non-small-cell Lung Cancer After Severe Immune-related Hepatitis: A Case Report.
    Clin Lung Cancer. 2019 Oct 13. pii: S1525-7304(19)30023.
    PubMed    


  229. OWEN B, Gandara D, Kelly K, Moore E, et al
    CT Volumetry and Basic Texture Analysis as Surrogate Markers in Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2019 Oct 8. pii: S1525-7304(19)30253.
    PubMed     Abstract available


  230. BENNOUNA J, Girard N, Audigier-Valette C, le Thuaut A, et al
    Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial.
    Clin Lung Cancer. 2019 Oct 1. pii: S1525-7304(19)30265.
    PubMed     Abstract available


    September 2019
  231. WIDICK P, Gill RR, Mantia C, Costa DB, et al
    Extensive-Stage Small-Cell Lung Cancer With Sustained Complete Response to Single-Agent Nivolumab and Immune-Related Dermatitis.
    Clin Lung Cancer. 2019 Sep 26. pii: S1525-7304(19)30263.
    PubMed    


  232. AL-OBEIDI E, Li T, Kelly K
    Durable Responses to Afatinib as First-line Therapy for HER2-mutated Metastatic Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2019 Sep 26. pii: S1525-7304(19)30264.
    PubMed    


  233. XIA H, Xue X, Ding H, Ou Q, et al
    Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR+ NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer.
    Clin Lung Cancer. 2019 Sep 26. pii: S1525-7304(19)30262.
    PubMed     Abstract available


  234. PHAM D, Bhandari S, Pinkston C, Oechsli M, et al
    Lung Cancer Screening Registry Reveals Low-dose CT Screening Remains Heavily Underutilized.
    Clin Lung Cancer. 2019 Sep 26. pii: S1525-7304(19)30260.
    PubMed     Abstract available


  235. RICE SR, Vyfhuis MAL, Scilla KA, Burrows WM, et al
    Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non-small-cell Lung Cancer Treated With Curative Intent.
    Clin Lung Cancer. 2019 Sep 18. pii: S1525-7304(19)30258.
    PubMed     Abstract available


    August 2019
  236. DUMA N, Idossa DW, Durani U, Frank RD, et al
    Influence of Sociodemographic Factors on Treatment Decisions in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2019 Aug 30. pii: S1525-7304(19)30254.
    PubMed     Abstract available


  237. AGULLO-ORTUNO MT, Gomez-Martin O, Ponce S, Iglesias L, et al
    Blood Predictive Biomarkers for Patients With Non-small-cell Lung Cancer Associated With Clinical Response to Nivolumab.
    Clin Lung Cancer. 2019 Aug 30. pii: S1525-7304(19)30255.
    PubMed     Abstract available


  238. WU GX, Ituarte PHG, Ferrell B, Sun V, et al
    Causes of Death and Hospitalization in Long-term Lung Cancer Survivors: A Population-based Appraisal.
    Clin Lung Cancer. 2019 Aug 30. pii: S1525-7304(19)30256.
    PubMed     Abstract available


  239. DAL MASO A, Lorenzi M, Roca E, Pilotto S, et al
    Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non-small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy.
    Clin Lung Cancer. 2019 Aug 5. pii: S1525-7304(19)30213.
    PubMed     Abstract available


  240. HEEKE S, Benzaquen J, Hofman V, Ilie M, et al
    Critical Assessment in Routine Clinical Practice of Liquid Biopsy for EGFR Status Testing in Non-Small-Cell Lung Cancer: A Single-Laboratory Experience (LPCE, Nice, France).
    Clin Lung Cancer. 2019 Aug 3. pii: S1525-7304(19)30214.
    PubMed     Abstract available


  241. BOVER M, Yarza R, Docampo LI
    Four-Year Lasting Sustained Complete Response After Nivolumab in a Patient With Non-Small-Cell Lung Cancer and Confirmed Leptomeningeal Carcinomatosis: Changing the Paradigm.
    Clin Lung Cancer. 2019 Aug 3. pii: S1525-7304(19)30216.
    PubMed    


  242. UPRETY D, Arjyal L, Vallatharasu Y, Bista A, et al
    Utilization of Surgery and Its Impact on Survival in Patients With Early Stage Small-cell Lung Cancer in the United States.
    Clin Lung Cancer. 2019 Aug 2. pii: S1525-7304(19)30217.
    PubMed     Abstract available


  243. MITCHELL KG, Farooqi A, Ludmir EB, Corsini EM, et al
    Improved Overall Survival With Comprehensive Local Consolidative Therapy in Synchronous Oligometastatic Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2019 Aug 1. pii: S1525-7304(19)30211.
    PubMed     Abstract available


  244. FUKIHARA J, Sakamoto K, Koyama J, Ito T, et al
    Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non-Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors.
    Clin Lung Cancer. 2019 Aug 1. pii: S1525-7304(19)30210.
    PubMed     Abstract available


    July 2019
  245. NISHIO M, Sugawara S, Atagi S, Akamatsu H, et al
    Subgroup Analysis of Japanese Patients in a Phase III Study of Atezolizumab in Extensive-stage Small-cell Lung Cancer (IMpower133).
    Clin Lung Cancer. 2019 Jul 31. pii: S1525-7304(19)30209.
    PubMed     Abstract available


  246. GU F, Zhao C, Jiang T, Li X, et al
    Association Between Nicotine-dependent Gene Polymorphism and Smoking Cessation in Patients With Lung Cancer.
    Clin Lung Cancer. 2019 Jul 17. pii: S1525-7304(19)30206.
    PubMed     Abstract available


  247. CHENG H, Hosgood HD, Deng L, Ye K, et al
    Survival Disparities in Black Patients With EGFR-mutated Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2019 Jul 17. pii: S1525-7304(19)30207.
    PubMed     Abstract available


    June 2019
  248. SAKAKIBARA-KONISHI J, Kitai H, Ikezawa Y, Hatanaka Y, et al
    Response to Crizotinib Re-administration After Progression on Lorlatinib in a Patient With ALK-rearranged Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2019 Jun 26. pii: S1525-7304(19)30172.
    PubMed    


  249. WU JY, Yu CJ, Shih JY
    Effectiveness of Treatments for Advanced Non-Small-Cell Lung Cancer With Exon 20 Insertion Epidermal Growth Factor Receptor Mutations.
    Clin Lung Cancer. 2019 Jun 26. pii: S1525-7304(19)30169.
    PubMed     Abstract available


  250. SRIDHAR S, Paz-Ares L, Liu H, Shen K, et al
    Prognostic Significance of Liver Metastasis in Durvalumab-Treated Lung Cancer Patients.
    Clin Lung Cancer. 2019 Jun 26. pii: S1525-7304(19)30171.
    PubMed     Abstract available


  251. WEN J
    Comment on the data of the article titled "Second Primary Non-Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients".
    Clin Lung Cancer. 2019 Jun 26. pii: S1525-7304(19)30174.
    PubMed    


  252. SCOTTI V, Bruni A, Perna M, Vasilyeva P, et al
    Response to Letter to the Editor Titled "Surgery or Stereotactic Body Radiotherapy for Early Stage Lung Cancer: What is the Current Evidence?"
    Clin Lung Cancer. 2019 Jun 19. pii: S1525-7304(19)30158.
    PubMed    


  253. GUDENKAUF LM, Clark MM, Novotny PJ, Piderman KM, et al
    Spirituality and Emotional Distress Among Lung Cancer Survivors.
    Clin Lung Cancer. 2019 Jun 19. pii: S1525-7304(19)30157.
    PubMed     Abstract available


  254. TOLWIN Y, Gillis R, Agmon IN, Shrem NS, et al
    Increased Incidence of Lung Cancer Among Patients With Superficial Transitional Cell Carcinoma: A Potential Risk Cohort for Lung Cancer Screening.
    Clin Lung Cancer. 2019 Jun 18. pii: S1525-7304(19)30152.
    PubMed     Abstract available


  255. TIAN S, Zhang X, Jiang R, Pillai RN, et al
    Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.
    Clin Lung Cancer. 2019 Jun 18. pii: S1525-7304(19)30156.
    PubMed     Abstract available


  256. ZHAO Y, Zhang B, Wang S, Qiao R, et al
    Management of Central Nervous System Metastases in Patients With Advanced Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer During Crizotinib Treatment.
    Clin Lung Cancer. 2019 Jun 18. pii: S1525-7304(19)30155.
    PubMed     Abstract available


  257. CHIARI R, Ricciuti B, Landi L, Morelli AM, et al
    ROS1-rearranged Non-small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS).
    Clin Lung Cancer. 2019 Jun 18. pii: S1525-7304(19)30154.
    PubMed     Abstract available


  258. GUO D, Jin F, Jing W, Li M, et al
    Incorporation of the SUVmax Measured From FDG PET and Neutrophil-to-lymphocyte Ratio Improves Prediction of Clinical Outcomes in Patients With Locally Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2019 Jun 15. pii: S1525-7304(19)30150.
    PubMed     Abstract available


  259. VAN DE KAMP HJ, Molder MT, Schulkes KJG, Stellingwerf M, et al
    Impact of Lung Cancer Treatment on Cognitive Functioning.
    Clin Lung Cancer. 2019 Jun 15. pii: S1525-7304(19)30148.
    PubMed     Abstract available


  260. UPRETY D, Arjyal L, Vallatharasu Y, Bista A, et al
    Durable Response After 2 Doses of Pembrolizumab in a Patient With Non-Small-Cell Lung Cancer With an Isolated Brain Metastasis.
    Clin Lung Cancer. 2019 Jun 13. pii: S1525-7304(19)30144.
    PubMed    


  261. MAZZELLA A, Loi M, Mansuet-Lupo A, Bobbio A, et al
    Clinical Characteristics, Molecular Phenotyping, and Management of Isolated Adrenal Metastases From Lung Cancer.
    Clin Lung Cancer. 2019 Jun 13. pii: S1525-7304(19)30145.
    PubMed     Abstract available


  262. KAMIGAICHI A, Tsutani Y, Fujiwara M, Mimae T, et al
    Postoperative Recurrence and Survival After Segmentectomy for Clinical Stage 0 or IA Lung Cancer.
    Clin Lung Cancer. 2019 Jun 13. pii: S1525-7304(19)30146.
    PubMed     Abstract available


  263. LACOUR M, Hiltbrunner S, Lee SY, Soltermann A, et al
    Adjuvant Chemotherapy Increases Programmed Death-Ligand 1 (PD-L1) Expression in Non-small Cell Lung Cancer Recurrence.
    Clin Lung Cancer. 2019 Jun 5. pii: S1525-7304(19)30140.
    PubMed     Abstract available


  264. BORKENHAGEN JF, Bergom CR, Rapp CT, Klawikowski SJ, et al
    Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Lung Cancer.
    Clin Lung Cancer. 2019 Jun 5. pii: S1525-7304(19)30141.
    PubMed     Abstract available


    May 2019
  265. WANG S, Hao J, Qian C, Wang H, et al
    Tumor Spread Through Air Spaces Is a Survival Predictor in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2019 May 29. pii: S1525-7304(19)30139.
    PubMed     Abstract available


  266. JIANG Y, Liu LS, Shen LP, Liu JX, et al
    Traditional Chinese Medicine Treatment as Adjuvant Therapy in Completely Resected Stage IB-IIIA Non-Small-Cell Lung Cancer: Study Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.
    Clin Lung Cancer. 2019 May 21. pii: S1525-7304(19)30138.
    PubMed     Abstract available


  267. RAUMA V, Andersson S, Robinson EM, Rasanen JV, et al
    Thoracotomy and VATS Surgery in Local Non-Small-Cell Lung Cancer: Differences in Long-Term Health-Related Quality Of Life.
    Clin Lung Cancer. 2019 May 16. pii: S1525-7304(19)30137.
    PubMed     Abstract available


  268. TEGLASI V, Pipek O, Lozsa R, Berta K, et al
    PD-L1 Expression of Lung Cancer Cells, Unlike Infiltrating Immune Cells, Is Stable and Unaffected by Therapy During Brain Metastasis.
    Clin Lung Cancer. 2019 May 15. pii: S1525-7304(19)30112.
    PubMed     Abstract available


  269. PINSOLLE J, Mondet J, Duruisseaux M, d'Alnoncourt S, et al
    A Rare Fusion of CLIP1 and ALK in a Case of Non-Small-Cell Lung Cancer With Neuroendocrine Features.
    Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30105.
    PubMed    


  270. KIM R, Keam B, Hahn S, Ock CY, et al
    First-line Pembrolizumab Versus Pembrolizumab Plus Chemotherapy Versus Chemotherapy Alone in Non-small-cell Lung Cancer: A Systematic Review and Network Meta-analysis.
    Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30113.
    PubMed     Abstract available


  271. IKARI T, Sakakibara-Konishi J, Yamamoto G, Kitai H, et al
    Response to First-Line Osimertinib Treatment in Non-Small-Cell Lung Cancer With Coexisting G719A and Primary T790M Epidermal Growth Factor Receptor Mutations.
    Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30106.
    PubMed    


  272. MENDOZA DP, Stowell J, Muzikansky A, Shepard JO, et al
    Computed Tomography Imaging Characteristics of Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements: A Systematic Review and Meta-Analysis.
    Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30110.
    PubMed     Abstract available


  273. SCHILD SE, Zhao L, Wampfler JA, Daniels TB, et al
    Small-cell Lung Cancer in Very Elderly (>/= 80 Years) Patients.
    Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30111.
    PubMed     Abstract available


  274. MARTIN J, Lehmann A, Klauschen F, Hummel M, et al
    Clinical Impact of Rare and Compound Mutations of Epidermal Growth Factor Receptor in Patients With Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30103.
    PubMed     Abstract available


  275. CHINNIAH C, Aguarin L, Cheng P, Decesaris C, et al
    Early Detection of Recurrence in Patients With Locally Advanced Non-Small-Cell Lung Cancer via Circulating Tumor Cell Analysis.
    Clin Lung Cancer. 2019 May 4. pii: S1525-7304(19)30102.
    PubMed     Abstract available


  276. MEZQUITA L, Benito A, Ruano-Ravina A, Zamora J, et al
    Indoor Radon in EGFR- and BRAF-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer Patients.
    Clin Lung Cancer. 2019 May 3. pii: S1525-7304(19)30100.
    PubMed     Abstract available


    April 2019
  277. RADES D, Motisi L, Veninga T, Conde-Moreno A, et al
    Predictors of Outcomes and a Scoring System for Estimating Survival in Patients Treated With Radiotherapy for Metastatic Spinal Cord Compression From Small-Cell Lung Cancer.
    Clin Lung Cancer. 2019 Apr 26. pii: S1525-7304(19)30085.
    PubMed     Abstract available


  278. ALBERTS L, Wolff HB, Kastelijn EA, Lagerwaard FJ, et al
    Patient-reported Outcomes After the Treatment of Early Stage Non-small-cell Lung Cancer With Stereotactic Body Radiotherapy Compared With Surgery.
    Clin Lung Cancer. 2019 Apr 25. pii: S1525-7304(19)30081.
    PubMed     Abstract available


  279. SCHWARTZBERG L, Korytowsky B, Penrod JR, Zhang Y, et al
    Real-World Clinical Impact of Immune Checkpoint Inhibitors in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer After Platinum Chemotherapy.
    Clin Lung Cancer. 2019 Apr 19. pii: S1525-7304(19)30084.
    PubMed     Abstract available


  280. DUDNIK E, Bar J, Peled N, Bshara E, et al
    Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life Cohort.
    Clin Lung Cancer. 2019 Apr 5. pii: S1525-7304(19)30080.
    PubMed     Abstract available


  281. LUTFI W, Schuchert MJ, Dhupar R, Ekeke C, et al
    Node-Positive Segmentectomy for Non-Small-Cell Lung Cancer: Risk Factors and Outcomes.
    Clin Lung Cancer. 2019 Apr 1. pii: S1525-7304(19)30079.
    PubMed     Abstract available


    March 2019
  282. CHOI M, Keam B, Ock CY, Kim M, et al
    Pemetrexed in the Treatment of Leptomeningeal Metastasis in Patients With EGFR-mutant Lung Cancer.
    Clin Lung Cancer. 2019 Mar 29. pii: S1525-7304(19)30078.
    PubMed     Abstract available


  283. VOONG KR, Hazell SZ, Fu W, Hu C, et al
    Relationship Between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients With Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2019 Mar 28. pii: S1525-7304(19)30068.
    PubMed     Abstract available


  284. KOH Y, Yagi S, Akamatsu H, Kanai K, et al
    Heterogeneous Expression of Programmed Death Receptor-ligand 1 on Circulating Tumor Cells in Patients With Lung Cancer.
    Clin Lung Cancer. 2019 Mar 25. pii: S1525-7304(19)30077.
    PubMed     Abstract available


  285. YU T, Shin IS, Yoon WS, Rim CH, et al
    Stereotactic Body Radiotherapy for Centrally Located Primary Non-Small-Cell Lung Cancer: A Meta-Analysis.
    Clin Lung Cancer. 2019 Mar 19. pii: S1525-7304(19)30073.
    PubMed     Abstract available


  286. LI H, Verma V, Brooks ED, Feng L, et al
    Impact of Corticosteroid Administration on Outcomes Following Stereotactic Ablative Radiotherapy for Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2019 Mar 15. pii: S1525-7304(19)30074.
    PubMed     Abstract available


  287. VOONG KR, Liang OS, Dugan P, Torto D, et al
    Thoracic Oncology Multidisciplinary Clinic Reduces Unnecessary Health Care Expenditure Used in the Workup of Patients With Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2019 Mar 12. pii: S1525-7304(19)30060.
    PubMed     Abstract available


  288. BUDNIK J, DeNunzio NJ, Singh DP, Milano MT, et al
    Second Primary Non-Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients.
    Clin Lung Cancer. 2019 Mar 4. pii: S1525-7304(19)30067.
    PubMed     Abstract available


  289. NAKAMURA M, Kageyama SI, Niho S, Okumura M, et al
    Impact of EGFR Mutation and ALK Translocation on Recurrence Pattern After Definitive Chemoradiotherapy for Inoperable Stage III Non-squamous Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2019 Mar 4. pii: S1525-7304(19)30071.
    PubMed     Abstract available


  290. REN H, Hou X, Eiken PW, Zhang J, et al
    Identification and Development of a Lung Adenocarcinoma PDX Model With STRN-ALK Fusion.
    Clin Lung Cancer. 2019;20:e142-e147.
    PubMed    


  291. PASSARO A, Prelaj A, Bonanno L, Tiseo M, et al
    Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations.
    Clin Lung Cancer. 2019;20:e186-e194.
    PubMed     Abstract available


  292. ROTOW JK, Woodard GA, Urisman A, McCoach CE, et al
    Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping Mutation.
    Clin Lung Cancer. 2019;20:e137-e141.
    PubMed    


  293. WU T, Zhou F, Soodeen-Lalloo AK, Yang X, et al
    The Association Between Imaging Features of TSCT and the Expression of PD-L1 in Patients With Surgical Resection of Lung Adenocarcinoma.
    Clin Lung Cancer. 2019;20:e195-e207.
    PubMed     Abstract available


  294. NIKITAS J, DeWees T, Rehman S, Abraham C, et al
    Stereotactic Body Radiotherapy for Early-Stage Multiple Primary Lung Cancers.
    Clin Lung Cancer. 2019;20:107-116.
    PubMed     Abstract available


  295. CASIRAGHI M, Guarize J, Sandri A, Maisonneuve P, et al
    Pneumonectomy in Stage IIIA-N2 NSCLC: Should It Be Considered After Neoadjuvant Chemotherapy?
    Clin Lung Cancer. 2019;20:97-106.
    PubMed     Abstract available


    February 2019
  296. RICCIUTI B, Genova C, Bassanelli M, De Giglio A, et al
    Safety and Efficacy of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer Treated Beyond Progression.
    Clin Lung Cancer. 2019 Feb 27. pii: S1525-7304(19)30020.
    PubMed     Abstract available


  297. HIRANUMA O, Uchino J, Yamada T, Chihara Y, et al
    Rationale and Design of a Phase II Trial of Osimertinib Combined With Bevacizumab in Patients With Untreated Epidermal Growth Factor Receptor-mutated Non-small-cell Lung Cancer and Malignant Pleural and/or Pericardial Effusion (SPIRAL II Study).
    Clin Lung Cancer. 2019 Feb 27. pii: S1525-7304(19)30066.
    PubMed     Abstract available


  298. DING M, Deng L, Yu R, Lu D, et al
    Case Report: Temporal Heterogeneity of ALK Activating Mutations in Sequential ALK TKI-Treated Non-Small-Cell Lung Cancer Revealed Using NGS-Based Liquid Biopsy.
    Clin Lung Cancer. 2019 Feb 27. pii: S1525-7304(19)30064.
    PubMed    


  299. WINTHER-LARSEN A, Fynboe Ebert EB, Meldgaard P, Sorensen BS, et al
    EGFR Gene Polymorphism Predicts Improved Outcome in Patients With EGFR Mutation-positive Non-small cell Lung Cancer Treated With Erlotinib.
    Clin Lung Cancer. 2019 Feb 26. pii: S1525-7304(19)30061.
    PubMed     Abstract available


  300. CLAVE S, Rodon N, Pijuan L, Diaz O, et al
    Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non-small-cell Lung Cancer: Implications of FISH-positive Patterns.
    Clin Lung Cancer. 2019 Feb 26. pii: S1525-7304(19)30058.
    PubMed     Abstract available


  301. WEI YF, Lim CK, Tsai MS, Huang MS, et al
    Intracranial Responses to Afatinib at Different Doses in Patients With EGFR-mutated Non-small-cell Lung Carcinoma and Brain Metastases.
    Clin Lung Cancer. 2019 Feb 26. pii: S1525-7304(19)30059.
    PubMed     Abstract available


  302. CODONY-SERVAT J, Codony-Servat C, Cardona AF, Gimenez-Capitan A, et al
    Cancer Stem Cell Biomarkers in EGFR-Mutation-Positive Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2019 Feb 21. pii: S1525-7304(19)30024.
    PubMed     Abstract available


  303. FELD E, Singhi EK, Phillips S, Huang LC, et al
    Palliative Care Referrals for Advanced Non-small-cell Lung Cancer (NSCLC): Patient and Provider Attitudes and Practices.
    Clin Lung Cancer. 2019 Feb 20. pii: S1525-7304(19)30021.
    PubMed     Abstract available


    January 2019
  304. PACHECO J, Bunn PA
    Advancements in Small-cell Lung Cancer: The Changing Landscape Following IMpower-133.
    Clin Lung Cancer. 2019 Jan 2. pii: S1525-7304(18)30356.
    PubMed     Abstract available


  305. RAZ DJ, Wu G, Nelson RA, Sun V, et al
    Perceptions and Utilization of Lung Cancer Screening Among Smokers Enrolled in a Tobacco Cessation Program.
    Clin Lung Cancer. 2019;20:e115-e122.
    PubMed     Abstract available


  306. ZHU YC, Wang WX, Zhang QX, Xu CW, et al
    The KIF5B-RET Fusion Gene Mutation as a Novel Mechanism of Acquired EGFR Tyrosine Kinase Inhibitor Resistance in Lung Adenocarcinoma.
    Clin Lung Cancer. 2019;20:e73-e76.
    PubMed    


  307. SCOTTI V, Bruni A, Francolini G, Perna M, et al
    Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis.
    Clin Lung Cancer. 2019;20:e53-e61.
    PubMed     Abstract available


  308. HU F, Xu J, Zhang B, Li C, et al
    Efficacy of Local Consolidative Therapy for Oligometastatic Lung Adenocarcinoma Patients Harboring Epidermal Growth Factor Receptor Mutations.
    Clin Lung Cancer. 2019;20:e81-e90.
    PubMed     Abstract available


  309. KAUFFMANN-GUERRERO D, Kahnert K, Kumbrink J, Syunyaeva Z, et al
    Successful Treatment of a Patient With NSCLC Harboring an EGFR Mutation and a Concomitant Met Exon 14 Skipping Mutation Combining Afatinib and Crizotinib.
    Clin Lung Cancer. 2019;20:59-62.
    PubMed    


  310. LAM VK, Tran HT, Banks KC, Lanman RB, et al
    Targeted Tissue and Cell-Free Tumor DNA Sequencing of Advanced Lung Squamous-Cell Carcinoma Reveals Clinically Significant Prevalence of Actionable Alterations.
    Clin Lung Cancer. 2019;20:30-36.
    PubMed     Abstract available


  311. FODOR A, Broggi S, Incerti E, Dell'Oca I, et al
    Moderately Hypofractionated Helical IMRT, FDG-PET/CT-guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs.
    Clin Lung Cancer. 2019;20:e29-e38.
    PubMed     Abstract available


    December 2018
  312. WANG B, Gao Y, Huang Y, Ou Q, et al
    Durable Clinical Response to Crizotinib in IRF2BP2-NTRK1 Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Dec 31. pii: S1525-7304(18)30354.
    PubMed    


  313. LEE J, Sun JM, Lee SH, Ahn JS, et al
    Efficacy and Safety of Lorlatinib in Korean Non-Small-Cell Lung Cancer Patients With ALK or ROS1 Rearrangement Whose Disease Failed to Respond to a Previous Tyrosine Kinase Inhibitor.
    Clin Lung Cancer. 2018 Dec 31. pii: S1525-7304(18)30357.
    PubMed     Abstract available


  314. NOKIHARA H, Nishio M, Yamamoto N, Fujiwara Y, et al
    Phase 1 Study of Cabozantinib in Japanese Patients With Expansion Cohorts in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Dec 31. pii: S1525-7304(18)30355.
    PubMed     Abstract available


  315. CERRA-FRANCO A, Liu S, Azar M, Shiue K, et al
    Predictors of Nodal and Metastatic Failure in Early Stage Non-small-cell Lung Cancer After Stereotactic Body Radiation Therapy.
    Clin Lung Cancer. 2018 Dec 29. pii: S1525-7304(18)30353.
    PubMed     Abstract available


  316. EZEIFE DA, Morganstein BJ, Lau S, Law JH, et al
    Financial Burden Among Patients With Lung Cancer in a Publically Funded Health Care System.
    Clin Lung Cancer. 2018 Dec 22. pii: S1525-7304(18)30334.
    PubMed     Abstract available


  317. SCHWARZ M, Kocher F, Niedersuess-Beke D, Rudzki J, et al
    Immunosuppression for Immune Checkpoint-related Toxicity Can Cause Pneumocystis Jirovecii Pneumonia (PJP) in Non-small-cell Lung Cancer (NSCLC): A Report of 2 Cases.
    Clin Lung Cancer. 2018 Dec 19. pii: S1525-7304(18)30330.
    PubMed    


  318. WANG L, Zhan C, Gu J, Xi J, et al
    Role of Skip Mediastinal Lymph Node Metastasis for Patients With Resectable Non-small-cell Lung Cancer: A Propensity Score Matching Analysis.
    Clin Lung Cancer. 2018 Dec 19. pii: S1525-7304(18)30331.
    PubMed     Abstract available


  319. PARK W, Lopes G
    Perspectives: Neutrophil-to-lymphocyte Ratio as a Potential Biomarker in Immune Checkpoint Inhibitor for Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Dec 19. pii: S1525-7304(18)30327.
    PubMed     Abstract available


  320. BEAU-FALLER M, Texier M, Blons H, Richard N, et al
    Clinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non-small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2).
    Clin Lung Cancer. 2018 Dec 19. pii: S1525-7304(18)30336.
    PubMed     Abstract available


  321. TOMASINI P, Mascaux C, Jao K, Labbe C, et al
    Effect of Coexisting KRAS and TP53 Mutations in Patients Treated With Chemotherapy for Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Dec 19. pii: S1525-7304(18)30333.
    PubMed     Abstract available


  322. JANSSENS A, Derijcke S, Galdermans D, Daenen M, et al
    Prognostic Understanding and Quality of Life in Patients With Advanced Lung Cancer: A Multicenter Study.
    Clin Lung Cancer. 2018 Dec 13. pii: S1525-7304(18)30307.
    PubMed     Abstract available


  323. AKAMATSU H, Teraoka S, Koh Y, Yamanaka T, et al
    A Phase II Study of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer who Responded to Prior PD-1/L1 Inhibitors: West Japan Oncology Group 9616L (WJOG9616L).
    Clin Lung Cancer. 2018 Dec 11. pii: S1525-7304(18)30325.
    PubMed     Abstract available


  324. JIANG T, Zhao J, Zhao C, Li X, et al
    Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients Treated With First-Line EGFR Tyrosine Kinase Inhibitors.
    Clin Lung Cancer. 2018 Dec 4. pii: S1525-7304(18)30310.
    PubMed     Abstract available


    November 2018
  325. SAKAMOTO MR, Honce JM, Lindquist DL, Camidge DR, et al
    Lorlatinib Salvages CNS Relapse in an ALK-Positive Non-Small-Cell Lung Cancer Patient Previously Treated With Crizotinib and High-Dose Brigatinib.
    Clin Lung Cancer. 2018 Nov 29. pii: S1525-7304(18)30306.
    PubMed    


  326. KWON YJ, You NY, Lee JW, Kim J, et al
    High Receipt of Statins Reduces the Risk of Lung Cancer in Current Smokers With Hypercholesterolemia: The National Health Insurance Service-Health Screening Cohort.
    Clin Lung Cancer. 2018 Nov 29. pii: S1525-7304(18)30305.
    PubMed     Abstract available


  327. SUZUKI R, Wei X, Allen PK, Cox JD, et al
    Prognostic Significance of Total Lymphocyte Count, Neutrophil-to-lymphocyte Ratio, and Platelet-to-lymphocyte Ratio in Limited-stage Small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Nov 29. pii: S1525-7304(18)30309.
    PubMed     Abstract available


  328. WHEATLEY-PRICE P, Gadgeel S, Takahashi T, Li X, et al
    Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Patients With Previously Untreated Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Nov 29. pii: S1525-7304(18)30308.
    PubMed     Abstract available


  329. SONG Z, Wang H, Yu Z, Lu P, et al
    De Novo MET Amplification in Chinese Patients With Non-Small-Cell Lung Cancer and Treatment Efficacy With Crizotinib: A Multicenter Retrospective Study.
    Clin Lung Cancer. 2018 Nov 26. pii: S1525-7304(18)30303.
    PubMed     Abstract available


  330. UPRETY D
    Chemo-immunotherapy: The Beginning of a New Era in Lung Cancer.
    Clin Lung Cancer. 2018 Nov 22. pii: S1525-7304(18)30302.
    PubMed    


  331. DALWADI SM, Lewis GD, Bernicker EH, Butler EB, et al
    Disparities in the Treatment and Outcome of Stage I Non-Small-Cell Lung Cancer in the 21st Century.
    Clin Lung Cancer. 2018 Nov 20. pii: S1525-7304(18)30300.
    PubMed     Abstract available


  332. KATSUMATA S, Aokage K, Nakasone S, Sakai T, et al
    Radiologic Criteria in Predicting Pathologic Less Invasive Lung Cancer According to TNM 8th Edition.
    Clin Lung Cancer. 2018 Nov 15. pii: S1525-7304(18)30297.
    PubMed     Abstract available


  333. ABDULLA DSY, Scheffler M, Brandes V, Ruge M, et al
    Monitoring Treatment Response to Erlotinib in EGFR-mutated Non-small-cell Lung Cancer Brain Metastases Using Serial O-(2-[(18)F]fluoroethyl)-L-tyrosine PET.
    Clin Lung Cancer. 2018 Nov 5. pii: S1525-7304(18)30295.
    PubMed    


  334. ROSSI S, Toschi L, Finocchiaro G, Di Noia V, et al
    Impact of Exon 19 Deletion Subtypes in EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer Treated With First-Line Tyrosine Kinase Inhibitors.
    Clin Lung Cancer. 2018 Nov 2. pii: S1525-7304(18)30293.
    PubMed     Abstract available


  335. PATEL JD, Paz-Ares L, Zinner RG, Barlesi F, et al
    Pemetrexed Continuation Maintenance Phase 3 Trials in Nonsquamous, Non-Small-Cell Lung Cancer: Focus on 2-Year Overall Survival and Continuum of Care.
    Clin Lung Cancer. 2018;19:e823-e830.
    PubMed     Abstract available


  336. XIE H, Wang H, Xu L, Li M, et al
    Gefitinib Versus Adjuvant Chemotherapy in Patients With Stage II-IIIA Non-Small-Cell Lung Cancer Harboring Positive EGFR Mutations: A Single-Center Retrospective Study.
    Clin Lung Cancer. 2018;19:484-492.
    PubMed     Abstract available


  337. SCHLEI Z, Tan W, Faber MG, Chen H, et al
    Safety of Same-Day Vitamin B12 Supplementation in Patients Receiving Pemetrexed for the Treatment of Non-Small-Cell Lung Cancer or Pleural Mesothelioma: A Retrospective Analysis.
    Clin Lung Cancer. 2018;19:467-475.
    PubMed     Abstract available


  338. NINOMIYA T, Ishikawa N, Inoue K, Kubo T, et al
    Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol.
    Clin Lung Cancer. 2018 Nov 1. pii: S1525-7304(18)30292.
    PubMed     Abstract available


    October 2018
  339. MA K, Zhan C, Wang S, Shi Y, et al
    Spread Through Air Spaces (STAS): A New Pathologic Morphology in Lung Cancer.
    Clin Lung Cancer. 2018 Oct 26. pii: S1525-7304(18)30268.
    PubMed     Abstract available


  340. HELLERSTEDT BA, Vogelzang NJ, Kluger HM, Yasenchak CA, et al
    Results of a Phase II Placebo-controlled Randomized Discontinuation Trial of Cabozantinib in Patients with Non-small-cell Lung Carcinoma.
    Clin Lung Cancer. 2018 Oct 24. pii: S1525-7304(18)30267.
    PubMed     Abstract available


  341. MYALL NJ, Henry S, Wood D, Neal JW, et al
    Natural Disease History, Outcomes, and Co-mutations in a Series of Patients With BRAF-Mutated Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Oct 23. pii: S1525-7304(18)30264.
    PubMed     Abstract available


  342. SEYMOUR L, Le Teuff G, Brambilla E, Shepherd FA, et al
    LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Oct 11. pii: S1525-7304(18)30262.
    PubMed     Abstract available


  343. KIM EK, Kim KA, Lee CY, Kim S, et al
    Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Oct 11. pii: S1525-7304(18)30265.
    PubMed     Abstract available


  344. GRANGEON M, Tomasini P, Chaleat S, Jeanson A, et al
    Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Oct 11. pii: S1525-7304(18)30263.
    PubMed     Abstract available


    September 2018
  345. CHAE YK, Davis AA, Raparia K, Agte S, et al
    Association of Tumor Mutational Burden With DNA Repair Mutations and Response to Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Sep 25. pii: S1525-7304(18)30253.
    PubMed     Abstract available


  346. PIRKER R, Filipits M
    Adjuvant Therapy in Patients With Completely Resected Non-small-cell Lung Cancer: Current Status and Perspectives.
    Clin Lung Cancer. 2018 Sep 24. pii: S1525-7304(18)30261.
    PubMed     Abstract available


  347. ELAMIN YY, Gomez DR, Antonoff MB, Robichaux JP, et al
    Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non-small-cell Lung Cancer (NSCLC).
    Clin Lung Cancer. 2018 Sep 24. pii: S1525-7304(18)30260.
    PubMed     Abstract available


  348. MENG X, Gao Y, Yang L, Jing H, et al
    Immune Microenvironment Differences Between Squamous and Non-squamous Non-small-cell Lung Cancer and Their Influence on the Prognosis.
    Clin Lung Cancer. 2018 Sep 24. pii: S1525-7304(18)30257.
    PubMed     Abstract available


  349. RICE SR, Molitoris JK, Vyfhuis MAL, Edelman MJ, et al
    Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non-small-cell Lung Cancer at Diagnosis.
    Clin Lung Cancer. 2018 Sep 24. pii: S1525-7304(18)30259.
    PubMed     Abstract available


  350. KSIENSKI D, Wai ES, Croteau N, Fiorino L, et al
    Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter Analysis.
    Clin Lung Cancer. 2018 Sep 22. pii: S1525-7304(18)30250.
    PubMed     Abstract available


  351. ZHU VW, Lu Y, Ignatius Ou SH
    Severe Acute Hepatitis in a Patient Receiving Alectinib for ALK-Positive Non-Small-Cell Lung Cancer: Histologic Analysis.
    Clin Lung Cancer. 2018 Sep 21. pii: S1525-7304(18)30251.
    PubMed    


  352. SCHONEWOLF CA, Heskel M, Doucette A, Singhal S, et al
    Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location.
    Clin Lung Cancer. 2018 Sep 20. pii: S1525-7304(18)30237.
    PubMed     Abstract available


  353. MILLER CJ, Martin B, Stang K, Hutten R, et al
    Predictors of Distant Failure After Stereotactic Body Radiation Therapy for Stages I to IIA Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Sep 8. pii: S1525-7304(18)30235.
    PubMed     Abstract available


  354. NG TL, Yu H, Smith DE, Boyle TA, et al
    Preselection of Lung Cancer Cases Using FGFR1 mRNA and Gene Copy Number for Treatment With Ponatinib.
    Clin Lung Cancer. 2018 Sep 7. pii: S1525-7304(18)30234.
    PubMed     Abstract available


  355. BERRY MF, Canchola AJ, Gensheimer MF, Gomez SL, et al
    Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis.
    Clin Lung Cancer. 2018;19:e745-e758.
    PubMed     Abstract available


  356. REN S, Rivard CJ, Yu H, Genova C, et al
    A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell Lines.
    Clin Lung Cancer. 2018;19:450-456.
    PubMed     Abstract available


  357. OH IJ, Hur JY, Park CK, Kim YC, et al
    Clinical Activity of Pan-HER Inhibitors Against HER2-Mutant Lung Adenocarcinoma.
    Clin Lung Cancer. 2018;19:e775-e781.
    PubMed     Abstract available


  358. DELANEY FT, Fong KM, Lee JC
    Incidental Pulmonary Malignancies on CTAC in MPS.
    Clin Lung Cancer. 2018;19:e801-e802.
    PubMed    


  359. TAMURA T, Ojima E, Satoh H
    Lung Cancers Detected on Computed Tomography Attenuation Correction Images During Myocardial Perfusion Scintigraphy.
    Clin Lung Cancer. 2018;19:e709.
    PubMed    


  360. RAMAN S, Yau V, Pineda S, Le LW, et al
    Ultracentral Tumors Treated With Stereotactic Body Radiotherapy: Single-Institution Experience.
    Clin Lung Cancer. 2018;19:e803-e810.
    PubMed     Abstract available


  361. VITTORIO A, Sharma R, Siejka D, Bhattarai K, et al
    Recurrent Pericardial Effusion While Receiving Nivolumab for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature.
    Clin Lung Cancer. 2018;19:e717-e720.
    PubMed    


  362. ANDERSSON S, Ilonen I, Jarvinen T, Rauma V, et al
    Surgically Treated Unsuspected N2-Positive NSCLC: Role of Extent and Location of Lymph Node Metastasis.
    Clin Lung Cancer. 2018;19:418-425.
    PubMed     Abstract available


  363. MATSUOKA H, Kimura H, Koba H, Tambo Y, et al
    Nivolumab-induced Limbic Encephalitis with Anti-Hu Antibody in a Patient With Advanced Pleomorphic Carcinoma of the Lung.
    Clin Lung Cancer. 2018;19:e597-e599.
    PubMed    


  364. FUJIMOTO N, Aoe K, Kozuki T, Oze I, et al
    A Phase II Trial of First-Line Combination Chemotherapy With Cisplatin, Pemetrexed, and Nivolumab for Unresectable Malignant Pleural Mesothelioma: A Study Protocol.
    Clin Lung Cancer. 2018;19:e705-e707.
    PubMed     Abstract available


  365. ZHANG C, Li F, Li J, Xu Y, et al
    Docetaxel Down-Regulates PD-1 Expression via STAT3 in T Lymphocytes.
    Clin Lung Cancer. 2018;19:e675-e683.
    PubMed     Abstract available


  366. SHAABAN SG, Verma V, Choi JI, Shabason J, et al
    Utilization of Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United States.
    Clin Lung Cancer. 2018;19:e685-e692.
    PubMed     Abstract available


    August 2018
  367. AKAMATSU H, Harada H, Tokunaga S, Yoshimura N, et al
    A Phase II Study of Gefitinib With Concurrent Thoracic Radiotherapy in Patients With Unresectable, Stage III Non-small-cell Lung Cancer Harboring EGFR Mutations (WJOG6911L).
    Clin Lung Cancer. 2018 Aug 30. pii: S1525-7304(18)30230.
    PubMed     Abstract available


  368. KIM E, Wu HG, Keam B, Kim TM, et al
    Significance of (18)F-FDG PET Parameters According to Histologic Subtype in the Treatment Outcome of Stage III Non-small-cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy.
    Clin Lung Cancer. 2018 Aug 30. pii: S1525-7304(18)30231.
    PubMed     Abstract available


  369. GRASS GD, Naghavi AO, Abuodeh YA, Perez BA, et al
    Analysis of Relapse Events After Definitive Chemoradiotherapy in Locally Advanced Non-Small-Cell Lung Cancer Patients.
    Clin Lung Cancer. 2018 Aug 29. pii: S1525-7304(18)30203.
    PubMed     Abstract available


  370. WU F, Lin X, Yang Z, Sun Z, et al
    Phase III Randomized Trial of Palonosetron and Dexamethasone With or Without Aprepitant to Prevent Nausea and Vomiting Induced by Full-dose Single-day Cisplatin-based Chemotherapy in Lung Cancer.
    Clin Lung Cancer. 2018 Aug 23. pii: S1525-7304(18)30200.
    PubMed     Abstract available


  371. ZHAO X, Feng Z, Wang G, Pang H, et al
    Ceritinib Alone for Crizotinib-naive Versus Crizotinib-pretreated for Management of Anaplastic Lymphoma Kinase-rearrangement Non-Small-cell Lung Cancer: A Systematic Review.
    Clin Lung Cancer. 2018 Aug 23. pii: S1525-7304(18)30207.
    PubMed     Abstract available


  372. YU TM, Morrison C, Gold EJ, Tradonsky A, et al
    Multiple Biomarker Testing Tissue Consumption and Completion Rates With Single-gene Tests and Investigational Use of Oncomine Dx Target Test for Advanced Non-Small-cell Lung Cancer: A Single-center Analysis.
    Clin Lung Cancer. 2018 Aug 23. pii: S1525-7304(18)30204.
    PubMed     Abstract available


  373. WAINER Z, Wright GM, Gough K, Daniels MG, et al
    Sex-Dependent Staging in Non-Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging System.
    Clin Lung Cancer. 2018 Aug 22. pii: S1525-7304(18)30198.
    PubMed     Abstract available


  374. SUZUKI R, Wei X, Allen PK, Welsh JW, et al
    Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis.
    Clin Lung Cancer. 2018 Aug 22. pii: S1525-7304(18)30206.
    PubMed     Abstract available


  375. IAMS WT, Yu H, Shyr Y, Patil T, et al
    First-line Chemotherapy Responsiveness and Patterns of Metastatic Spread Identify Clinical Syndromes Present Within Advanced KRAS Mutant Non-Small-cell Lung Cancer With Different Prognostic Significance.
    Clin Lung Cancer. 2018 Aug 22. pii: S1525-7304(18)30205.
    PubMed     Abstract available


  376. OWEN DH, Wei L, Bertino EM, Edd T, et al
    Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Aug 22. pii: S1525-7304(18)30202.
    PubMed     Abstract available


  377. FARRELL MJ, Yahya JB, Degnin C, Chen Y, et al
    Radiation Dose and Fractionation for Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Practice Patterns.
    Clin Lung Cancer. 2018 Aug 22. pii: S1525-7304(18)30209.
    PubMed     Abstract available


  378. RENAUD S, Guerrera F, Seitlinger J, Reeb J, et al
    KRAS-specific Amino Acid Substitutions are Associated With Different Responses to Chemotherapy in Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Aug 22. pii: S1525-7304(18)30199.
    PubMed     Abstract available


  379. HATA A, Katakami N, Shimokawa M, Mitsudomi T, et al
    Docetaxel Plus RAmucirumab With Primary Prophylactic Pegylated Granulocyte-ColONy Stimulating Factor Support for Elderly Patients With Advanced Non-small-cell Lung Cancer: A Multicenter Prospective Single Arm Phase II Trial: DRAGON Study (WJOG9416L).
    Clin Lung Cancer. 2018 Aug 7. pii: S1525-7304(18)30193.
    PubMed     Abstract available


  380. BARBIE DA, Spira A, Kelly K, Humeniuk R, et al
    Phase 1B Study of Momelotinib Combined With Trametinib in Metastatic, Kirsten Rat Sarcoma Viral Oncogene Homolog-Mutated Non-Small-Cell Lung Cancer After Platinum-Based Chemotherapy Treatment Failure.
    Clin Lung Cancer. 2018 Aug 4. pii: S1525-7304(18)30171.
    PubMed     Abstract available


    July 2018
  381. CUMMINGS MA, Ma SJ, Hermann G, Serra L, et al
    Comparison of Single- and Five-fraction Regimens of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non-small-cell Lung Cancer: A Two-institution Propensity-matched Analysis.
    Clin Lung Cancer. 2018 Jul 30. pii: S1525-7304(18)30190.
    PubMed     Abstract available


  382. IIJIMA Y, Hirotsu Y, Mochizuki H, Amemiya K, et al
    Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Jul 26. pii: S1525-7304(18)30169.
    PubMed    


  383. VERMA V, Schonewolf CA, Cushman TR, Post CM, et al
    Impact of Enlarged Nonhypermetabolic Lymph Nodes on Outcomes After Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Jul 25. pii: S1525-7304(18)30172.
    PubMed     Abstract available


  384. DRIESSEN EJM, Janssen-Heijnen MLG, Maas HA, Dingemans AC, et al
    Study Protocol of the NVALT25-ELDAPT Trial: Selecting the Optimal Treatment for Older Patients With Stage III Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Jul 9. pii: S1525-7304(18)30170.
    PubMed     Abstract available


  385. WU YL, Herbst RS, Mann H, Rukazenkov Y, et al
    ADAURA: Phase III, Double-blind, Randomized Study of Osimertinib Versus Placebo in EGFR Mutation-positive Early-stage NSCLC After Complete Surgical Resection.
    Clin Lung Cancer. 2018;19:e533-e536.
    PubMed     Abstract available


    June 2018
  386. CHANG H, Yang Y, Lee JS, Jheon SH, et al
    Epidermal Growth Factor Receptor Gene Amplification Predicts Worse Outcome in Patients With Surgically Resected Nonadenocarcinoma Lung Cancer.
    Clin Lung Cancer. 2018 Jun 27. pii: S1525-7304(18)30162.
    PubMed     Abstract available


  387. WU F, Zhang S, Xiong A, Gao G, et al
    A Phase II Clinical Trial of Apatinib in Pretreated Advanced Non-squamous Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Jun 27. pii: S1525-7304(18)30161.
    PubMed     Abstract available


  388. RAGHAVAN G, Shaverdian N, Chan S, Chu FI, et al
    Comparing Outcomes of Patients With Early-Stage Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy Based on Frailty Status.
    Clin Lung Cancer. 2018 Jun 6. pii: S1525-7304(18)30128.
    PubMed     Abstract available


  389. ARUNACHALAM A, Li H, Bittoni MA, Camacho R, et al
    Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Jun 6. pii: S1525-7304(18)30136.
    PubMed     Abstract available


  390. LEE A, Howell VM, Itchins M, Wheeler HR, et al
    ROS1-Rearranged Non-Small-Cell Lung Cancer, Factor V Leiden, and Recurrent Venous Thromboses.
    Clin Lung Cancer. 2018 Jun 5. pii: S1525-7304(18)30135.
    PubMed    


  391. SU CT, Bhargava A, Shah CD, Halmos B, et al
    Screening Patterns and Mortality Differences in Patients With Lung Cancer at an Urban Underserved Community.
    Clin Lung Cancer. 2018 Jun 5. pii: S1525-7304(18)30139.
    PubMed     Abstract available


    May 2018
  392. PAOLINI D, Tiseo M, Demma F, Furneri G, et al
    Ventana ALK (D5F3) in the Detection of Patients Affected by Anaplastic Lymphoma Kinase-positive Non-Small-cell Lung Cancer: Clinical and Budget Effect.
    Clin Lung Cancer. 2018 May 31. pii: S1525-7304(18)30132.
    PubMed     Abstract available


  393. BORDONI R, Ciardiello F, von Pawel J, Cortinovis D, et al
    Patient-Reported Outcomes in OAK: A Phase III Study of Atezolizumab Versus Docetaxel in Advanced Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2018 May 31. pii: S1525-7304(18)30131.
    PubMed     Abstract available


  394. KAWACHI H, Fujimoto D, Morimoto T, Ito M, et al
    Clinical Characteristics and Prognosis of Patients With Advanced Non-Small-cell Lung Cancer Who Are Ineligible for Clinical Trials.
    Clin Lung Cancer. 2018 May 26. pii: S1525-7304(18)30134.
    PubMed     Abstract available


  395. KOGURE Y, Saka H, Takiguchi Y, Atagi S, et al
    A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol.
    Clin Lung Cancer. 2018 May 19. pii: S1525-7304(18)30110.
    PubMed     Abstract available


  396. RAMAN S, Bissonnette JP, Warner A, Le L, et al
    Rationale and Protocol for a Canadian Multicenter Phase II Randomized Trial Assessing Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-small-cell Lung Cancer (NCT02788461).
    Clin Lung Cancer. 2018 May 16. pii: S1525-7304(18)30107.
    PubMed     Abstract available


  397. RODRIGUEZ DE DIOS N, Counago F, Lopez JL, Calvo P, et al
    Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radia
    Clin Lung Cancer. 2018 May 10. pii: S1525-7304(18)30108.
    PubMed     Abstract available


  398. SAIKI M, Kitazono S, Yoshizawa T, Dotsu Y, et al
    Characterization of Computed Tomography Imaging of Rearranged During Transfection-rearranged Lung Cancer.
    Clin Lung Cancer. 2018 May 10. pii: S1525-7304(18)30088.
    PubMed     Abstract available


  399. ZER A, Sung MR, Walia P, Khoja L, et al
    Correlation of Neutrophil to Lymphocyte Ratio and Absolute Neutrophil Count With Outcomes With PD-1 Axis Inhibitors in Patients With Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 May 8. pii: S1525-7304(18)30090.
    PubMed     Abstract available


  400. LOONG HH, Raymond VM, Shiotsu Y, Chua DTT, et al
    Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia.
    Clin Lung Cancer. 2018 May 7. pii: S1525-7304(18)30104.
    PubMed     Abstract available


  401. BITTONI MA, Arunachalam A, Li H, Camacho R, et al
    Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non-small-cell Lung Cancer: A Retrospective Study.
    Clin Lung Cancer. 2018 May 7. pii: S1525-7304(18)30099.
    PubMed     Abstract available


  402. HIRSH V, Wan Y, Lin FJ, Margunato-Debay S, et al
    Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non-Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin.
    Clin Lung Cancer. 2018 May 7. pii: S1525-7304(18)30105.
    PubMed     Abstract available


  403. FUJIMOTO D, Sato Y, Morimoto T, Uehara K, et al
    Programmed Cell Death Ligand 1 Expression in Non-Small-cell Lung Cancer Patients With Interstitial Lung Disease: A Matched Case-control Study.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30094.
    PubMed     Abstract available


  404. FUKUI T, Okuma Y, Nakahara Y, Otani S, et al
    Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30103.
    PubMed     Abstract available


  405. GINESTET F, Lambros L, Le Flahec G, Marcorelles P, et al
    Evaluation of a Dual ALK/ROS1 Fluorescent In Situ Hybridization Test in Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30098.
    PubMed     Abstract available


  406. FACCHINETTI F, Gnetti L, Caruana P, Fornaroli F, et al
    Widespread Nivolumab-induced Enteropathy in a Long Responder Non-Small-cell Lung Cancer Patient.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30095.
    PubMed    


  407. LAMBROS L, Uguen A
    Toward a Molecular Diagnosis in a Single Day for Patients With Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30044.
    PubMed    


  408. OKUMA Y, Wakui H, Utsumi H, Sagawa Y, et al
    Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30096.
    PubMed     Abstract available


  409. FARRELL MJ, Yahya JB, Degnin C, Chen Y, et al
    Timing of Thoracic Radiation Therapy With Chemotherapy in Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30089.
    PubMed     Abstract available


  410. ATAGI S, Mizusawa J, Ishikura S, Takahashi T, et al
    Chemoradiotherapy in Elderly Patients With Non-Small-Cell Lung Cancer: Long-Term Follow-Up of a Randomized Trial (JCOG0301).
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30100.
    PubMed     Abstract available


  411. VANDERLAAN PA, Chen Y, DiStasio M, Rangachari D, et al
    Molecular Testing Turnaround Time in Non-Small-Cell Lung Cancer: Monitoring a Moving Target.
    Clin Lung Cancer. 2018 May 4. pii: S1525-7304(18)30087.
    PubMed    


    April 2018
  412. CHIN AL, Kumar KA, Guo HH, Maxim PG, et al
    Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Apr 19. pii: S1525-7304(18)30085.
    PubMed     Abstract available


  413. GIULIANI M, Mathew AS, Bahig H, Bratman SV, et al
    SUNSET: Stereotactic Radiation for Ultracentral Non-Small-Cell Lung Cancer-A Safety and Efficacy Trial.
    Clin Lung Cancer. 2018 Apr 18. pii: S1525-7304(18)30073.
    PubMed     Abstract available


    March 2018
  414. PAXIMADIS P, Beebe-Dimmer JL, George J, Schwartz AG, et al
    Comparing Treatment Strategies for Stage I Small-cell lung Cancer.
    Clin Lung Cancer. 2018 Mar 23. pii: S1525-7304(18)30059.
    PubMed     Abstract available


  415. GIACCONE G, Sanborn RE, Waqar SN, Martinez-Marti A, et al
    A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer and Systemic Inflammation.
    Clin Lung Cancer. 2018 Mar 23. pii: S1525-7304(18)30058.
    PubMed     Abstract available


  416. HIRSCH FR, Kerr KM, Bunn PA Jr, Kim ES, et al
    Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.
    Clin Lung Cancer. 2018 Mar 21. pii: S1525-7304(18)30056.
    PubMed     Abstract available


  417. WU YL, Sequist LV, Tan EH, Geater SL, et al
    Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials.
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30051.
    PubMed     Abstract available


  418. REIS H, Metzenmacher M, Goetz M, Savvidou N, et al
    MET Expression in Advanced Non-Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy.
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30052.
    PubMed     Abstract available


  419. GRILLEY-OLSON JE, Weiss J, Ivanova A, Villaruz LC, et al
    Phase Ib Study of Bavituximab With Carboplatin and Pemetrexed in Chemotherapy-Naive Advanced Nonsquamous Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30050.
    PubMed     Abstract available


  420. TOH CK, Ong WS, Lim WT, Tan DS, et al
    A Decade of Never-smokers Among Lung Cancer Patients-Increasing Trend and Improved Survival.
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30055.
    PubMed     Abstract available


  421. KIM CR, Kim B, Ning MS, Reddy JP, et al
    Cost Analysis of PET/CT Versus CT as Surveillance for Stage III Non-Small-Cell Lung Cancer After Definitive Radiation Therapy.
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30054.
    PubMed     Abstract available


  422. VISSER S, de Mol M, Cheung K, van Toor JJ, et al
    Treatment Satisfaction of Patients With Advanced Non-Small-cell Lung Cancer Receiving Platinum-based Chemotherapy: Results From a Prospective Cohort Study (PERSONAL).
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30045.
    PubMed     Abstract available


  423. DEEK MP, Kim S, Beck R, Yegya-Raman N, et al
    Variations in Initiation Dates of Chemotherapy and Radiation Therapy for Definitive Management of Inoperable Non-Small Cell Lung Cancer Are Associated With Decreases in Overall Survival.
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30049.
    PubMed     Abstract available


  424. ARDESHIR-LARIJANI F, Bhateja P, Lipka MB, Sharma N, et al
    KMT2D Mutation Is Associated With Poor Prognosis in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Mar 16. pii: S1525-7304(18)30047.
    PubMed     Abstract available


  425. SIO TT, Prayongrat A, Zhang Y, Lin Q, et al
    The Road Less Traveled: Should We Omit Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer?
    Clin Lung Cancer. 2018 Mar 16. pii: S1525-7304(18)30048.
    PubMed     Abstract available


  426. WAQAR SN, Samson PP, Robinson CG, Bradley J, et al
    Non-small-cell Lung Cancer With Brain Metastasis at Presentation.
    Clin Lung Cancer. 2018 Mar 8. pii: S1525-7304(18)30019.
    PubMed     Abstract available


    February 2018
  427. FARRELL MJ, Yahya JB, Degnin C, Chen Y, et al
    Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns.
    Clin Lung Cancer. 2018 Feb 23. pii: S1525-7304(18)30042.
    PubMed     Abstract available


  428. PETRELLI F, Maltese M, Tomasello G, Conti B, et al
    Clinical and Molecular Predictors of PD-L1 Expression in Non-Small-Cell Lung Cancer: Systematic Review and Meta-analysis.
    Clin Lung Cancer. 2018 Feb 21. pii: S1525-7304(18)30025.
    PubMed     Abstract available


  429. STONE CJL, Vaid HM, Selvam R, Ashworth A, et al
    Multidisciplinary Clinics in Lung Cancer Care: A Systematic Review.
    Clin Lung Cancer. 2018 Feb 21. pii: S1525-7304(18)30020.
    PubMed     Abstract available


  430. TAKASHIMA Y, Sakakibara-Konishi J, Hatanaka Y, Hatanaka KC, et al
    Clinicopathologic Features and Immune Microenvironment of Non-Small-cell Lung Cancer With Primary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
    Clin Lung Cancer. 2018 Feb 19. pii: S1525-7304(18)30023.
    PubMed     Abstract available


  431. NADLER E, Espirito JL, Pavilack M, Boyd M, et al
    Treatment Patterns and Clinical Outcomes Among Metastatic Non-Small-Cell Lung Cancer Patients Treated in the Community Practice Setting.
    Clin Lung Cancer. 2018 Feb 17. pii: S1525-7304(18)30021.
    PubMed     Abstract available


  432. WU TH, Hsiue EH, Lee JH, Lin CC, et al
    Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non-Small-cell Lung Cancer Patients.
    Clin Lung Cancer. 2018 Feb 1. pii: S1525-7304(18)30017.
    PubMed     Abstract available


  433. BILFINGER TV, Albano D, Perwaiz M, Keresztes R, et al
    Survival Outcomes Among Lung Cancer Patients Treated Using a Multidisciplinary Team Approach.
    Clin Lung Cancer. 2018 Feb 1. pii: S1525-7304(18)30018.
    PubMed     Abstract available


  434. HIDA T, Kaji R, Satouchi M, Ikeda N, et al
    Atezolizumab in Japanese Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study.
    Clin Lung Cancer. 2018 Feb 1. pii: S1525-7304(18)30016.
    PubMed     Abstract available


    January 2018
  435. KHUNGER M, Jain P, Rakshit S, Pasupuleti V, et al
    Safety and Efficacy of PD-1/PD-L1 Inhibitors in Treatment-Naive and Chemotherapy-Refractory Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Clin Lung Cancer. 2018 Jan 10. pii: S1525-7304(18)30002.
    PubMed     Abstract available


  436. KOBAYASHI K, Nakachi I, Naoki K, Satomi R, et al
    Real-world Efficacy and Safety of Nivolumab for Advanced Non-Small-cell Lung Cancer: A Retrospective Multicenter Analysis.
    Clin Lung Cancer. 2018 Jan 5. pii: S1525-7304(18)30001.
    PubMed     Abstract available


  437. ZHENG Y, Shi A, Wang W, Yu H, et al
    Posttreatment Immune Parameters Predict Cancer Control and Pneumonitis in Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy.
    Clin Lung Cancer. 2018 Jan 4. pii: S1525-7304(17)30351.
    PubMed     Abstract available


  438. TAMURA T, Miyazaki K, Shiozawa T, Satoh H, et al
    Comparative Effectiveness and Resource Usage in Patients Receiving First-line Taxol-based Chemotherapy for Stage IV NSCLC.
    Clin Lung Cancer. 2018;19:e67.
    PubMed    


    December 2017
  439. GRIDELLI C, Baas P, Barlesi F, Ciardiello F, et al
    Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology.
    Clin Lung Cancer. 2017 Dec 22. pii: S1525-7304(17)30349.
    PubMed     Abstract available


  440. QIU T, Li W, Zhang T, Xing P, et al
    Distinct MET Protein Localization Associated With MET Exon 14 Mutation Types in Patients With Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Dec 21. pii: S1525-7304(17)30345.
    PubMed     Abstract available


  441. PARK W, Kwon D, Saravia D, Desai A, et al
    Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab.
    Clin Lung Cancer. 2017 Dec 21. pii: S1525-7304(17)30346.
    PubMed     Abstract available


  442. RAMALINGAM SS, Perol M, Reck M, Kowalyszyn RD, et al
    Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial.
    Clin Lung Cancer. 2017 Dec 21. pii: S1525-7304(17)30350.
    PubMed     Abstract available


  443. BERNHARDT D, Konig L, Aufderstrasse S, Krisam J, et al
    Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices.
    Clin Lung Cancer. 2017 Dec 15. pii: S1525-7304(17)30343.
    PubMed     Abstract available


  444. SHARMA S, McMillan MT, Doucette A, Cohen RB, et al
    Effect of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small-Cell Lung Cancer: A Propensity Score-Matched Analysis.
    Clin Lung Cancer. 2017 Dec 14. pii: S1525-7304(17)30342.
    PubMed     Abstract available


  445. SALEM A, Mistry H, Backen A, Hodgson C, et al
    Cell Death, Inflammation, Tumor Burden, and Proliferation Blood Biomarkers Predict Lung Cancer Radiotherapy Response and Correlate With Tumor Volume and Proliferation Imaging.
    Clin Lung Cancer. 2017 Dec 11. pii: S1525-7304(17)30341.
    PubMed     Abstract available


  446. HALD SM, Rakaee M, Martinez I, Richardsen E, et al
    LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival.
    Clin Lung Cancer. 2017 Dec 11. pii: S1525-7304(17)30340.
    PubMed     Abstract available


  447. STOY SP, Segal JP, Mueller J, Furtado LV, et al
    Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Dec 5. pii: S1525-7304(17)30322.
    PubMed     Abstract available


    November 2017
  448. MA SJ, Cummings M, Serra LM, Syed YA, et al
    Three- Versus Five-Fraction Regimens of Stereotactic Body Radiotherapy for Peripheral Early-Stage Non-Small-Cell Lung Cancer: A Two-Institution Propensity Score-Matched Analysis.
    Clin Lung Cancer. 2017 Nov 26. pii: S1525-7304(17)30319.
    PubMed     Abstract available


  449. DALWADI SM, Szeja SS, Bernicker EH, Butler EB, et al
    Practice Patterns and Outcomes in Elderly Stage I Non-Small-cell Lung Cancer: A 2004 to 2012 SEER Analysis.
    Clin Lung Cancer. 2017 Nov 21. pii: S1525-7304(17)30316.
    PubMed     Abstract available


  450. DAMHUIS RAM, Senan S, Belderbos JS
    Usage of Prophylactic Cranial Irradiation in Elderly Patients With Small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Nov 21. pii: S1525-7304(17)30317.
    PubMed     Abstract available


  451. MASSABEAU C, Khalifa J, Filleron T, Modesto A, et al
    Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non-Small-cell Lung Cancer: A Phase I Study.
    Clin Lung Cancer. 2017 Nov 21. pii: S1525-7304(17)30314.
    PubMed     Abstract available


  452. RECK M, Garon EB, Paz-Ares L, Ponce S, et al
    Randomized, Double-Blind Phase Ib/III Study of Erlotinib With Ramucirumab or Placebo in Previously Untreated EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer (RELAY): Phase Ib Results.
    Clin Lung Cancer. 2017 Nov 21. pii: S1525-7304(17)30315.
    PubMed     Abstract available


  453. SURA K, Grills IS, Vu CC, Stevens CW, et al
    Improved Survival With Increased Time-To-Radiation and Sequential Chemotherapy After Surgery for pN2 Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Nov 17. pii: S1525-7304(17)30305.
    PubMed     Abstract available


  454. LEE S, Song SY, Kim SS, Choi W, et al
    Feasible Optimization of Stereotactic Ablative Radiotherapy Dose by Tumor Size for Stage I Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Nov 14. pii: S1525-7304(17)30313.
    PubMed     Abstract available


  455. JIANG T, Liu H, Qiao M, Li X, et al
    Impact of Clinicopathologic Features on the Efficacy of PD-1/PD-L1 Inhibitors in Patients With Previously Treated Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Nov 9. pii: S1525-7304(17)30312.
    PubMed     Abstract available


    October 2017
  456. NAKAMURA H, Koizumi H, Sakai H, Kimura H, et al
    Accuracy of the cobas EGFR Mutation Assay in Non-small-cell Lung Cancer Compared With Three Laboratory-developed Tests.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30309.
    PubMed     Abstract available


  457. GOBBINI E, Pilotto S, Pasello G, Polo V, et al
    Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30306.
    PubMed     Abstract available


  458. ZHOU H, Zhang Y, Qiu Z, Chen G, et al
    Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30310.
    PubMed     Abstract available


  459. TAKADA K, Toyokawa G, Shoji F, Okamoto T, et al
    The Significance of the PD-L1 Expression in Non-Small-Cell Lung Cancer: Trenchant Double Swords as Predictive and Prognostic Markers.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30308.
    PubMed     Abstract available


  460. MA SJ, Serra LM, Syed YA, Hermann GM, et al
    Comparison of Single- and Three-fraction Schedules of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30304.
    PubMed     Abstract available


  461. JOHNSON DY, Short RG, Patz EF Jr
    Sequential CT Findings in Patients With Non-small-cell Lung Cancer Receiving Nivolumab.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30303.
    PubMed     Abstract available


  462. PELLEGRINO B, Facchinetti F, Bordi P, Silva M, et al
    Lung Toxicity in Non-Small-Cell Lung Cancer Patients Exposed to ALK Inhibitors: Report of a Peculiar Case and Systematic Review of the Literature.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30302.
    PubMed     Abstract available


  463. ITO K, Suzuki Y, Saiki H, Sakaguchi T, et al
    Utility of Liquid Biopsy by Improved PNA-LNA PCR Clamp Method for Detecting EGFR Mutation at Initial Diagnosis of Non-Small-Cell Lung Cancer: Observational Study of 190 Consecutive Cases in Clinical Practice.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30311.
    PubMed     Abstract available


  464. CUPP J, Culakova E, Poniewierski MS, Dale DC, et al
    Analysis of Factors Associated With In-hospital Mortality in Lung Cancer Chemotherapy Patients With Neutropenia.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30307.
    PubMed     Abstract available


  465. AGGARWAL C, Cohen RB, Yu E, Hwang WT, et al
    Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non-Small-cell Lung Cancer: Results of a Phase II Study.
    Clin Lung Cancer. 2017 Oct 19. pii: S1525-7304(17)30281.
    PubMed     Abstract available


  466. INOUE T, Tamiya M, Tamiya A, Nakahama K, et al
    Analysis of Early Death in Japanese Patients With Advanced Non-small-cell Lung Cancer Treated With Nivolumab.
    Clin Lung Cancer. 2017 Oct 13. pii: S1525-7304(17)30274.
    PubMed     Abstract available


  467. CIULEANU T, Socinski MA, Obasaju C, Luft AV, et al
    Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Oct 13. pii: S1525-7304(17)30278.
    PubMed     Abstract available


  468. KESARWALA AH, Lu DJ, Xanthopoulos E, Apisarnthanarax S, et al
    The Role of Advanced Imaging in Assessing Response to Definitive Chemoradiation Before Prophylactic Cranial Irradiation in Limited-Stage Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Oct 12. pii: S1525-7304(17)30275.
    PubMed     Abstract available


    September 2017
  469. MA L, Ye W, Li Q, Wang B, et al
    Subjective Global Assessment (SGA) Score Could Be a Predictive Factor for Radiation Pneumonitis in Lung Cancer Patients With Normal Pulmonary Function Treated by Intensity-Modulated Radiation Therapy and Concurrent Chemotherapy.
    Clin Lung Cancer. 2017 Sep 19. pii: S1525-7304(17)30259.
    PubMed     Abstract available


  470. LANGER CJ, Paz-Ares LG, Wozniak AJ, Gridelli C, et al
    Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies.
    Clin Lung Cancer. 2017;18:489-496.
    PubMed     Abstract available


  471. REMON J, Menis J, Hasan B, Peric A, et al
    The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613.
    Clin Lung Cancer. 2017;18:583-588.
    PubMed     Abstract available


  472. TOYOKAWA G, Takada K, Okamoto T, Kozuma Y, et al
    High Frequency of Programmed Death-ligand 1 Expression in Emphysematous Bullae-associated Lung Adenocarcinomas.
    Clin Lung Cancer. 2017;18:504-511.
    PubMed     Abstract available


  473. GIRARD P, Caliandro R, Seguin-Givelet A, Lenoir S, et al
    Sensitivity of Cytology Specimens From Bronchial Aspirate or Washing During Bronchoscopy in the Diagnosis of Lung Malignancies: An Update.
    Clin Lung Cancer. 2017;18:512-518.
    PubMed     Abstract available


    August 2017
  474. AKTHAR AS, Koshy M, Ferguson MK, Murgu S, et al
    Effect of Endoscopic Bronchial Ultrasound on Outcomes for Stage I Non-Small-Cell Lung Cancer Patients Receiving Hypofractionated Radiotherapy.
    Clin Lung Cancer. 2017 Aug 31. pii: S1525-7304(17)30231.
    PubMed     Abstract available


  475. HALTHORE A, Goenka A, Sharma R, Knisely JPS, et al
    Prophylactic Cranial Irradiation for Resectable Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Aug 26. pii: S1525-7304(17)30232.
    PubMed     Abstract available


  476. KIM E, Feldman R, Wistuba II
    Update on EGFR Mutational Testing and the Potential of Noninvasive Liquid Biopsy in Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Aug 12. pii: S1525-7304(17)30229.
    PubMed     Abstract available


  477. KAWAMURA T, Kenmotsu H, Omori S, Nakashima K, et al
    Clinical Factors Predicting Detection of T790M Mutation in Rebiopsy for EGFR-Mutant Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Aug 10. pii: S1525-7304(17)30210.
    PubMed     Abstract available


  478. BROSSEAU S, Gounant V, Naltet C, Theou-Anton N, et al
    Lazarus Syndrome With Crizotinib in a Non-Small Cell Lung Cancer Patient With ROS1 Rearrangement and Disseminated Intravascular Coagulation.
    Clin Lung Cancer. 2017 Aug 3. pii: S1525-7304(17)30211.
    PubMed    


    July 2017
  479. ALEXANDER M, Solomon B, Burbury K
    Thromboembolism in Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2017 Jul 22. pii: S1525-7304(17)30209.
    PubMed    


  480. ABUODEH Y, Naghavi AO, Echevarria M, DeMarco M, et al
    Quantitatively Excessive Normal Tissue Toxicity and Poor Target Coverage in Postoperative Lung Cancer Radiotherapy Meta-analysis.
    Clin Lung Cancer. 2017 Jul 8. pii: S1525-7304(17)30196.
    PubMed     Abstract available


  481. VERMA V, Simone CB 2nd
    Surgery Versus Conventional Radiation Therapy for T1-2 N0 M0 Small-cell Lung Cancer: A Fair Comparison?
    Clin Lung Cancer. 2017 Jul 6. pii: S1525-7304(17)30201.
    PubMed    


  482. YANG JC, Mok T, Han B, Orlando M, et al
    A Review of Regimens Combining Pemetrexed With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the Treatment of Advanced Nonsquamous Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Jul 6. pii: S1525-7304(17)30200.
    PubMed     Abstract available


  483. TAKAMORI S, Toyokawa G, Takada K, Shoji F, et al
    Combination Therapy of Radiotherapy and Anti-PD-1/PD-L1 Treatment in Non-Small-cell Lung Cancer: A Mini-review.
    Clin Lung Cancer. 2017 Jul 6. pii: S1525-7304(17)30202.
    PubMed     Abstract available


  484. SONNICK MA, Oro F, Yan B, Desai A, et al
    Identifying the Optimal Radiation Dose in Locally Advanced Non-Small-cell Lung Cancer Treated With Definitive Radiotherapy Without Concurrent Chemotherapy.
    Clin Lung Cancer. 2017 Jul 6. pii: S1525-7304(17)30206.
    PubMed     Abstract available


  485. WEST HL, Moon J, Wozniak AJ, Mack P, et al
    Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 Trials.
    Clin Lung Cancer. 2017 Jul 6. pii: S1525-7304(17)30203.
    PubMed     Abstract available


    June 2017
  486. QIAO M, Jiang T, Ren S, Zhou C, et al
    Combination Strategies on the Basis of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer: Where Do We Stand?
    Clin Lung Cancer. 2017 Jun 23. pii: S1525-7304(17)30178.
    PubMed     Abstract available


  487. ZUGAZAGOITIA J, Rueda D, Carrizo N, Enguita AB, et al
    Prospective Clinical Integration of an Amplicon-Based Next-Generation Sequencing Method to Select Advanced Non-Small-Cell Lung Cancer Patients for Genotype-Tailored Treatments.
    Clin Lung Cancer. 2017 Jun 23. pii: S1525-7304(17)30181.
    PubMed     Abstract available


  488. JIN F, Qu B, Fu Z, Zhang Y, et al
    Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on 18F-FDG PET/CT in Patients With Limited-stage Small-cell Lung Cancer With Lymph Node Involvement.
    Clin Lung Cancer. 2017 Jun 22. pii: S1525-7304(17)30179.
    PubMed     Abstract available


  489. DUDANI S, Zhu X, Yokom DW, Yamada A, et al
    Radical Treatment of Stage II Non-small-cell Lung Cancer With Nonsurgical Approaches: A Multi-institution Report of Outcomes.
    Clin Lung Cancer. 2017 Jun 21. pii: S1525-7304(17)30180.
    PubMed     Abstract available


  490. OTSUBO K, Kishimoto J, Kenmotsu H, Minegishi Y, et al
    Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non-Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis.
    Clin Lung Cancer. 2017 Jun 20. pii: S1525-7304(17)30176.
    PubMed     Abstract available


  491. GAUT D, Sim MS, Yue Y, Wolf BR, et al
    Clinical Implications of the T790M Mutation in Disease Characteristics and Treatment Response in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC).
    Clin Lung Cancer. 2017 Jun 20. pii: S1525-7304(17)30177.
    PubMed     Abstract available


  492. NOMA D, Inamura K, Matsuura Y, Hirata Y, et al
    Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Jun 20. pii: S1525-7304(17)30174.
    PubMed     Abstract available


  493. KALMAN NS, Weiss E, Walker PR, Rosenman JG, et al
    Local Radiotherapy Intensification for Locally Advanced Non-small-cell Lung Cancer - A Call to Arms.
    Clin Lung Cancer. 2017 Jun 16. pii: S1525-7304(17)30173.
    PubMed     Abstract available


  494. MCGEE SF, Zhang T, Jonker H, Laurie SA, et al
    The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Jun 8. pii: S1525-7304(17)30167.
    PubMed     Abstract available


  495. UMAKOSHI H, Iwano S, Yokoi K, Ito S, et al
    FDG PET/CT Overcomes Discordance Between Clinical and Pathologic TNM Classification of Small-size Primary Lung Cancer: Influence on Postoperative Prognosis.
    Clin Lung Cancer. 2017 Jun 8. pii: S1525-7304(17)30170.
    PubMed     Abstract available


  496. YAMAMOTO N, Kenmotsu H, Yamanaka T, Nakamura S, et al
    Randomized Phase III Study of Cisplatin With Pemetrexed and Cisplatin With Vinorelbine for Completely Resected Nonsquamous Non-Small-Cell Lung Cancer: The JIPANG Study Protocol.
    Clin Lung Cancer. 2017 Jun 8. pii: S1525-7304(17)30169.
    PubMed     Abstract available


  497. PILOTTO S, Rossi A, Vavala T, Follador A, et al
    Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study.
    Clin Lung Cancer. 2017 Jun 1. pii: S1525-7304(17)30165.
    PubMed     Abstract available


  498. RAZ DJ, Wu GX, Consunji M, Nelson RA, et al
    The Effect of Primary Care Physician Knowledge of Lung Cancer Screening Guidelines on Perceptions and Utilization of Low-Dose Computed Tomography.
    Clin Lung Cancer. 2017 Jun 1. pii: S1525-7304(17)30148.
    PubMed     Abstract available


  499. SADOYAMA S, Sekine A, Satoh H, Iwasawa T, et al
    Isolated Brain Metastases as the First Relapse After the Curative Surgical Resection in Non-Small-Cell Lung Cancer Patients With an EGFR Mutation.
    Clin Lung Cancer. 2017 Jun 1. pii: S1525-7304(17)30166.
    PubMed     Abstract available


    May 2017
  500. WOODARD GA, Wang SX, Kratz JR, Zoon-Besselink CT, et al
    Adjuvant Chemotherapy Guided by Molecular Profiling and Improved Outcomes in Early Stage, Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 May 31. pii: S1525-7304(17)30150.
    PubMed     Abstract available


  501. HAYASHI H, Chiba Y, Sakai K, Fujita T, et al
    A Randomized Phase II Study Comparing Nivolumab With Carboplatin-Pemetrexed for Patients With EGFR Mutation-Positive Nonsquamous Non-Small-Cell Lung Cancer Who Acquire Resistance to Tyrosine Kinase Inhibitors Not Due to a Secondary T790M Mutation: Rat
    Clin Lung Cancer. 2017 May 25. pii: S1525-7304(17)30147.
    PubMed     Abstract available


  502. WANG X, Yan S, Lv C, Wang Y, et al
    Impact of Omission of Intrapulmonary Lymph Node Retrieval on Outcome Evaluation of Lung Cancer Patients Without Lymph Node Metastasis: A Propensity Score Matching Analysis.
    Clin Lung Cancer. 2017 May 11. pii: S1525-7304(17)30136.
    PubMed     Abstract available


  503. FRELINGHUYSEN M, Fest J, Van der Voort Van Zyp NC, Van der Holt B, et al
    Consequences of Referral Time and Volume Doubling Time in Inoperable Patients With Early Stage Lung Cancer.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30137.
    PubMed     Abstract available


  504. SHIN JY, Yoon JK, Marwaha G
    External Validation of the New International Association for the Study of Lung Cancer Tumor, Node, and Metastasis 8th Edition Staging System and Updated T Descriptors in Determining Prognosis for Patients With Non-Small Cell Lung Cancer Patients With
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30144.
    PubMed     Abstract available


  505. NAKAMICHI S, Horinouchi H, Asao T, Goto Y, et al
    Comparison of Radiotherapy and Chemoradiotherapy for Locoregional Recurrence of Non-small-cell Lung Cancer Developing After Surgery.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30140.
    PubMed     Abstract available


  506. YOKOTA H, Sato K, Okuda Y, Kobayashi H, et al
    Effects of Histamine 2-receptor Antagonists and Proton Pump Inhibitors on the Pharmacokinetics of Gefitinib in Patients With Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30145.
    PubMed     Abstract available


  507. KATO R, Hayashi H, Chiba Y, Tanaka K, et al
    Prognostic Impact of Minimal Pericardial Effusion in Patients With Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30146.
    PubMed     Abstract available


  508. LEONG TL, Christie M, Kranz S, Pham K, et al
    Evaluating the Genomic Yield of a Single Endobronchial Ultrasound-guided Transbronchial Needle Aspiration in Lung Cancer: Meeting the Challenge of Doing More With Less.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30141.
    PubMed     Abstract available


  509. GLISSON B, Besse B, Dols MC, Dubey S, et al
    A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30142.
    PubMed     Abstract available


  510. RAJUPET S, Doshi D, Wisnivesky JP, Lin JJ, et al
    Attitudes About Lung Cancer Screening: Primary Care Providers Versus Specialists.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30138.
    PubMed     Abstract available


  511. GARCIA S, Saltarski JM, Yan J, Xie XJ, et al
    Time and Effort Required for Tissue Acquisition and Submission in Lung Cancer Clinical Trials.
    Clin Lung Cancer. 2017 May 8. pii: S1525-7304(17)30132.
    PubMed     Abstract available


  512. WU AJ, Garay E, Foster A, Hsu M, et al
    Definitive Radiotherapy for Local Recurrence of NSCLC After Surgery.
    Clin Lung Cancer. 2017;18:e161-e168.
    PubMed     Abstract available


  513. SUN V, Raz DJ, Ruel N, Chang W, et al
    A Multimedia Self-management Intervention to Prepare Cancer Patients and Family Caregivers for Lung Surgery and Postoperative Recovery.
    Clin Lung Cancer. 2017;18:e151-e159.
    PubMed     Abstract available


    April 2017
  514. AHMED HZ, Liu Y, O'Connell K, Ahmed MZ, et al
    Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.
    Clin Lung Cancer. 2017 Apr 28. pii: S1525-7304(17)30114.
    PubMed     Abstract available


  515. GANTI AK, Hirsch FR, Wynes MW, Ravelo A, et al
    Access to Cancer Specialist Care and Treatment in Patients With Advanced Stage Lung Cancer.
    Clin Lung Cancer. 2017 Apr 26. pii: S1525-7304(17)30115.
    PubMed     Abstract available


  516. FENSKE DC, Price GL, Hess LM, John WJ, et al
    Systematic Review of Brain Metastases in Patients With Non-Small-Cell Lung Cancer in the United States, European Union, and Japan.
    Clin Lung Cancer. 2017 Apr 26. pii: S1525-7304(17)30116.
    PubMed     Abstract available


  517. CHO JH, Sorensen SF, Choi YL, Feng Y, et al
    Programmed Death Ligand 1 Expression in Paired Non-Small Cell Lung Cancer Tumor Samples.
    Clin Lung Cancer. 2017 Apr 24. pii: S1525-7304(17)30113.
    PubMed     Abstract available


  518. DAHELE M, Damhuis RA
    Relationship Between Tumor Location and Outcome in Patients With Early-Stage Lung Cancer.
    Clin Lung Cancer. 2017 Apr 23. pii: S1525-7304(17)30110.
    PubMed    


  519. GIULIANI J, Bonetti A
    Nivolumab in Second-Line Treatment for Advanced Non-Small-Cell Lung Cancer With Squamous-Cell Histology: A Perspective Based on Pharmacologic Costs.
    Clin Lung Cancer. 2017 Apr 23. pii: S1525-7304(17)30112.
    PubMed    


  520. GUTIERREZ ME, Choi K, Lanman RB, Licitra EJ, et al
    Genomic Profiling of Advanced Non-Small Cell Lung Cancer in Community Settings: Gaps and Opportunities.
    Clin Lung Cancer. 2017 Apr 13. pii: S1525-7304(17)30109.
    PubMed     Abstract available


  521. QIU B, Liang Y, Li Q, Liu G, et al
    Local Therapy for Oligoprogressive Disease in Patients With Advanced Stage Non-small-cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutation.
    Clin Lung Cancer. 2017 Apr 12. pii: S1525-7304(17)30107.
    PubMed     Abstract available


  522. CHEN K, Chen H, Yang F, Sui X, et al
    Validation of the Eighth Edition of the TNM Staging System for Lung Cancer in 2043 Surgically Treated Patients With Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Apr 12. pii: S1525-7304(17)30106.
    PubMed     Abstract available


    March 2017
  523. AHMED Z, Kujtan L, Kennedy KF, Davis JR, et al
    Disparities in the Management of Patients With Stage I Small Cell Lung Carcinoma (SCLC): A Surveillance, Epidemiology and End Results (SEER) Analysis.
    Clin Lung Cancer. 2017 Mar 30. pii: S1525-7304(17)30080.
    PubMed     Abstract available


  524. SAKAMOTO S, Yamada T, Terazaki Y, Yoshiyama K, et al
    Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer.
    Clin Lung Cancer. 2017 Mar 24. pii: S1525-7304(17)30088.
    PubMed     Abstract available


  525. BATTISTI NML, Sehovic M, Extermann M
    Assessment of the External Validity of the National Comprehensive Cancer Network and European Society for Medical Oncology Guidelines for Non-Small-Cell Lung Cancer in a Population of Patients Aged 80 Years and Older.
    Clin Lung Cancer. 2017 Mar 21. pii: S1525-7304(17)30082.
    PubMed     Abstract available


  526. VERMA V, Rwigema JM, Adeberg S, Simone CB 2nd, et al
    Enrollment of Elderly Patients With Locally Advanced Non-Small Cell Lung Cancer in Multi-institutional Trials of Proton Beam Radiation Therapy.
    Clin Lung Cancer. 2017 Mar 16. pii: S1525-7304(17)30084.
    PubMed    


  527. CASSIDY RJ, Patel PR, Zhang X, Press RH, et al
    Stereotactic Body Radiotherapy for Early-stage Non-small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis.
    Clin Lung Cancer. 2017 Mar 16. pii: S1525-7304(17)30083.
    PubMed     Abstract available


  528. JUAN O, Popat S
    Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2017 Mar 14. pii: S1525-7304(17)30079.
    PubMed     Abstract available


  529. DISTASIO M, Chen Y, Rangachari D, Costa DB, et al
    Molecular Testing Turnaround Time for Non-Small Cell Lung Cancer in Routine Clinical Practice Confirms Feasibility of CAP/IASLC/AMP Guideline Recommendations: A Single-center Analysis.
    Clin Lung Cancer. 2017 Mar 14. pii: S1525-7304(17)30078.
    PubMed     Abstract available


  530. YONEDA KY, Scranton JR, Cadogan MA, Tassell V, et al
    Interstitial Lung Disease Associated With Crizotinib in Patients With Advanced Non-Small Cell Lung Cancer: Independent Review of Four PROFILE Trials.
    Clin Lung Cancer. 2017 Mar 14. pii: S1525-7304(17)30081.
    PubMed     Abstract available


  531. SCHULKES KJ, Souwer ET, van Elden LJ, Codrington H, et al
    Prognostic Value of Geriatric 8 and Identification of Seniors at Risk for Hospitalized Patients Screening Tools for Patients With Lung Cancer.
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30049.
    PubMed     Abstract available


  532. TAKADA K, Toyokawa G, Okamoto T, Shimokawa M, et al
    A Comprehensive Analysis of Programmed Cell Death Ligand-1 Expression With the Clone SP142 Antibody in Non-Small-Cell Lung Cancer Patients.
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30047.
    PubMed     Abstract available


  533. LI WN, Wang DF, Zhao YB, Qiu XS, et al
    Comparative Analysis for Diagnostic Yield of Small Cell Lung Cancer by Cytology and Histology During the Same Bronchoscopic Procedure.
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30052.
    PubMed     Abstract available


  534. SPIGEL DR, Luft A, Depenbrock H, Ramlau R, et al
    An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy With Necitumumab Versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30045.
    PubMed     Abstract available


  535. MORRISON EJ, Novotny PJ, Sloan JA, Yang P, et al
    Emotional Problems, Quality of Life, and Symptom Burden in Patients With Lung Cancer.
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30051.
    PubMed     Abstract available


  536. WU GX, Nelson RA, Kim JY, Raz DJ, et al
    Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30050.
    PubMed     Abstract available


  537. SONG Z, Wang X, Zheng Y, Su H, et al
    MET Gene Amplification and Overexpression in Chinese Non-Small-Cell Lung Cancer Patients Without EGFR Mutations.
    Clin Lung Cancer. 2017;18:213-219.
    PubMed     Abstract available


  538. GUILBAULT C, Garant A, Faria S, Owen S, et al
    Long-term Outcomes of Induction Carboplatin and Gemcitabine Followed by Concurrent Radiotherapy With Low-dose Paclitaxel and Gemcitabine for Stage III Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Mar 1. pii: S1525-7304(17)30046.
    PubMed     Abstract available


  539. MORIMOTO M, Okishio K, Akira M, Omachi N, et al
    Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017;18:e117-e127.
    PubMed     Abstract available


  540. ZHAO R, Kong W, Shang J, Zhe H, et al
    Hippocampal-Sparing Whole-Brain Radiotherapy for Lung Cancer.
    Clin Lung Cancer. 2017;18:127-131.
    PubMed     Abstract available


    February 2017
  541. ELLIS PM, Vella ET, Ung YC
    Immune Checkpoint Inhibitors for Patients With Advanced Non-Small-Cell Lung Cancer: A Systematic Review.
    Clin Lung Cancer. 2017 Feb 16. pii: S1525-7304(17)30043.
    PubMed     Abstract available


  542. QIN A, Street L, Cease K, Viglianti BL, et al
    Clinical Determinants of Durable Clinical Benefit of Pembrolizumab in Veterans With Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Feb 9. pii: S1525-7304(17)30041.
    PubMed     Abstract available


    January 2017
  543. SOO RA, Kubo A, Ando M, Kawaguchi T, et al
    Association Between Environmental Tobacco Smoke Exposure and the Occurrence of EGFR Mutations and ALK Rearrangements in Never-smokers With Non-Small-cell Lung Cancer: Analyses From a Prospective Multinational ETS Registry.
    Clin Lung Cancer. 2017 Jan 19. pii: S1525-7304(17)30020.
    PubMed     Abstract available


  544. SOCINSKI MA, Kaye FJ, Spigel DR, Kudrik FJ, et al
    Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage Disease.
    Clin Lung Cancer. 2017;18:68-76.
    PubMed     Abstract available


  545. YONESHIMA Y, Morita S, Ando M, Miura S, et al
    Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017;18:100-103.
    PubMed     Abstract available


    October 2016
  546. ZHANG Y, Zhang Z, Huang X, Kang S, et al
    Therapeutic Efficacy Comparison of 5 Major EGFR-TKIs in Advanced EGFR-positive Non-Small-cell Lung Cancer: A Network Meta-analysis Based on Head-to-Head Trials.
    Clin Lung Cancer. 2016 Oct 27. pii: S1525-7304(16)30231.
    PubMed     Abstract available


    May 2016
  547. PLANCHARD D, Yokoi T, McCleod MJ, Fischer JR, et al
    A Phase III Study of Durvalumab (MEDI4736) With or Without Tremelimumab for Previously Treated Patients With Advanced NSCLC: Rationale and Protocol Design of the ARCTIC Study.
    Clin Lung Cancer. 2016;17:232-236.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: